{
  "schema_version": "0.1.0",
  "case_id": "HR-NI020",
  "record_classification": {
    "synthetic": true,
    "banner": "SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD",
    "real_historical_name": true,
    "public_release_status": "draft"
  },
  "identity": {
    "person_id": "NI020",
    "display_name": "Frédéric Chopin",
    "aliases": [
      "Fryderyk Chopin",
      "Fryderyk Franciszek Chopin"
    ],
    "sex": "male",
    "era": "19th Century",
    "nationality": "Polish / French",
    "historical_dates": {
      "birth": {
        "preferred": {
          "iso": "1810-03-01",
          "display": "March 1, 1810",
          "precision": "day",
          "calendar": "gregorian"
        },
        "alternatives": [
          {
            "date": {
              "iso": "1810",
              "display": "1810",
              "precision": "year",
              "calendar": "gregorian"
            },
            "source_ids": [
              "SRC-0012"
            ],
            "resolution_status": "preferred",
            "note": "Roster year agrees with the cited sources."
          },
          {
            "date": {
              "iso": "1810-02-22",
              "display": "February 22, 1810",
              "precision": "day",
              "calendar": "gregorian"
            },
            "source_ids": [
              "SRC-0001",
              "SRC-0002"
            ],
            "resolution_status": "conflicting",
            "note": "His baptismal certificate, written several weeks after the birth, gives February 22; he and his family used March 1, which is preferred."
          }
        ]
      },
      "death": {
        "preferred": {
          "iso": "1849-10-17",
          "display": "October 17, 1849",
          "precision": "day",
          "calendar": "gregorian"
        },
        "alternatives": [
          {
            "date": {
              "iso": "1849",
              "display": "1849",
              "precision": "year",
              "calendar": "gregorian"
            },
            "source_ids": [
              "SRC-0012"
            ],
            "resolution_status": "preferred",
            "note": "Roster year agrees with the cited sources."
          }
        ]
      }
    },
    "synthetic_identity": {
      "mrn": "HR-NI020-SYN",
      "ssn": "000-20-8845",
      "date_of_birth": "1998-03-01",
      "name_policy": "real_historical_name",
      "fictional_facility": "St. Posthumous Health Center",
      "fictional_primary_clinician": "Matthias Lindqvist, MD",
      "fictional_consultant": {
        "name": "Ewa Kowalczyk-Grant, MD",
        "specialty": "Infectious Diseases"
      }
    }
  },
  "historical_timeline": [
    {
      "event_id": "EVT-0001",
      "date": {
        "iso": "1810-03-01",
        "display": "March 1, 1810",
        "precision": "day",
        "calendar": "gregorian"
      },
      "summary": "Born at Żelazowa Wola; the family moved to Warsaw within months.",
      "claim_ids": [
        "CLM-0001",
        "CLM-0002"
      ]
    },
    {
      "event_id": "EVT-0002",
      "date": {
        "iso": "1820",
        "display": "1820s",
        "precision": "decade",
        "calendar": "gregorian"
      },
      "summary": "Recurrent cough, fever, headaches, and swollen glands in his teens.",
      "claim_ids": [
        "CLM-0004"
      ]
    },
    {
      "event_id": "EVT-0003",
      "date": {
        "iso": "1827",
        "display": "1827",
        "precision": "year",
        "calendar": "gregorian"
      },
      "summary": "His youngest sister died of tuberculosis.",
      "claim_ids": [
        "CLM-0003"
      ]
    },
    {
      "event_id": "EVT-0004",
      "date": {
        "iso": "1830-11-02",
        "display": "November 2, 1830",
        "precision": "day",
        "calendar": "gregorian"
      },
      "summary": "Left Warsaw, never to return.",
      "claim_ids": [
        "CLM-0005"
      ]
    },
    {
      "event_id": "EVT-0005",
      "date": {
        "iso": "1831-09",
        "display": "September 1831",
        "precision": "month",
        "calendar": "gregorian"
      },
      "summary": "Settled in Paris, where he earned his living mainly by teaching.",
      "claim_ids": [
        "CLM-0005",
        "CLM-0006"
      ]
    },
    {
      "event_id": "EVT-0006",
      "date": {
        "iso": "1836",
        "display": "1836",
        "precision": "year",
        "calendar": "gregorian"
      },
      "summary": "An engagement made conditional on his health; met George Sand; seriously ill the following winter.",
      "claim_ids": [
        "CLM-0007",
        "CLM-0008"
      ]
    },
    {
      "event_id": "EVT-0007",
      "date": {
        "iso": "1838-11-08",
        "display": "November 8, 1838",
        "precision": "day",
        "calendar": "gregorian"
      },
      "summary": "Arrived on Majorca; gravely ill at Valldemossa through the winter.",
      "claim_ids": [
        "CLM-0009",
        "CLM-0010"
      ]
    },
    {
      "event_id": "EVT-0008",
      "date": {
        "iso": "1839-02",
        "display": "February 1839",
        "precision": "month",
        "calendar": "gregorian"
      },
      "summary": "Convalescence in Marseille, then Nohant.",
      "claim_ids": [
        "CLM-0011"
      ]
    },
    {
      "event_id": "EVT-0009",
      "date": {
        "iso": "1847-07",
        "display": "July 1847",
        "precision": "month",
        "calendar": "gregorian"
      },
      "summary": "Final parting from George Sand.",
      "claim_ids": [
        "CLM-0012"
      ]
    },
    {
      "event_id": "EVT-0016",
      "date": {
        "iso": "1840",
        "display": "1840s",
        "precision": "decade",
        "calendar": "gregorian"
      },
      "summary": "Chest pain, hemoptysis, and breathlessness later in life.",
      "claim_ids": [
        "CLM-0020"
      ]
    },
    {
      "event_id": "EVT-0010",
      "date": {
        "iso": "1848-11-16",
        "display": "November 16, 1848",
        "precision": "day",
        "calendar": "gregorian"
      },
      "summary": "Last concert, in London, despite frailty and fever.",
      "claim_ids": [
        "CLM-0013"
      ]
    },
    {
      "event_id": "EVT-0011",
      "date": {
        "iso": "1849-06-22",
        "display": "June 22, 1849",
        "precision": "day",
        "calendar": "gregorian"
      },
      "summary": "Two hemorrhages; tuberculosis diagnosed in its final stage.",
      "claim_ids": [
        "CLM-0014"
      ]
    },
    {
      "event_id": "EVT-0012",
      "date": {
        "iso": "1849-10-17",
        "display": "October 17, 1849",
        "precision": "day",
        "calendar": "gregorian"
      },
      "summary": "Died in Paris.",
      "claim_ids": [
        "CLM-0015"
      ]
    },
    {
      "event_id": "EVT-0013",
      "date": {
        "iso": "2003",
        "display": "2003",
        "precision": "year",
        "calendar": "gregorian"
      },
      "summary": "Cystic fibrosis and alpha-1 antitrypsin deficiency proposed as retrospective diagnoses.",
      "claim_ids": [
        "CLM-0017",
        "CLM-0018"
      ]
    },
    {
      "event_id": "EVT-0014",
      "date": {
        "iso": "2014",
        "display": "2014",
        "precision": "year",
        "calendar": "gregorian"
      },
      "summary": "Macroscopic examination of his preserved heart.",
      "claim_ids": [
        "CLM-0016"
      ]
    },
    {
      "event_id": "EVT-0015",
      "date": {
        "iso": "2018",
        "display": "2018",
        "precision": "year",
        "calendar": "gregorian"
      },
      "summary": "Heart failure with cirrhosis proposed as an alternative cause of death.",
      "claim_ids": [
        "CLM-0019"
      ]
    }
  ],
  "claims": [
    {
      "claim_id": "CLM-0001",
      "statement": "Fryderyk Franciszek Chopin was born in the village of Żelazowa Wola, in Mazovia, on March 1, 1810, according to his own statements and his family's; his baptismal certificate, written several weeks after the birth, gives February 22.",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "source_links": [
        {
          "source_id": "SRC-0001",
          "relationship": "supports"
        },
        {
          "source_id": "SRC-0002",
          "relationship": "supports"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    },
    {
      "claim_id": "CLM-0002",
      "statement": "His father, Mikołaj (Nicolas) Chopin, was a Frenchman from Lorraine who settled permanently in Poland and brought up his children as Poles; the family moved to Warsaw a few months after Fryderyk's birth.",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "clinical_interpretation": "Supports his Polish and French background.",
      "source_links": [
        {
          "source_id": "SRC-0001",
          "relationship": "supports"
        },
        {
          "source_id": "SRC-0002",
          "relationship": "supports"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    },
    {
      "claim_id": "CLM-0003",
      "statement": "In 1827 the youngest of the Chopin children, his sister Emilia, died of tuberculosis.",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "clinical_interpretation": "Family history of tuberculosis.",
      "source_links": [
        {
          "source_id": "SRC-0004",
          "relationship": "supports"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    },
    {
      "claim_id": "CLM-0004",
      "statement": "A review of the documentary sources reports recurrent episodes of cough, fever, headaches, and swollen lymph nodes beginning in his teens.",
      "evidence_grade": "D",
      "certainty": "probable",
      "clinical_interpretation": "Anchor for the lifelong chest illness behind the presenting problem.",
      "source_links": [
        {
          "source_id": "SRC-0010",
          "relationship": "supports"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    },
    {
      "claim_id": "CLM-0005",
      "statement": "He left Warsaw on November 2, 1830, never to return, reached Paris in September 1831, and in 1834 chose the status of a political refugee rather than apply to the Russian embassy for a passport.",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "clinical_interpretation": "Supports his life away from his homeland in the modern social history.",
      "source_links": [
        {
          "source_id": "SRC-0002",
          "relationship": "supports"
        },
        {
          "source_id": "SRC-0001",
          "relationship": "supports"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    },
    {
      "claim_id": "CLM-0006",
      "statement": "In Paris his most important source of income was giving lessons; he became a popular teacher, and although ranked among the greatest pianists of his time, he disliked public performances, appeared rarely, and preferred an intimate group of listeners.",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "clinical_interpretation": "Supports his modern occupation as a pianist who earns his living by teaching.",
      "source_links": [
        {
          "source_id": "SRC-0001",
          "relationship": "supports"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    },
    {
      "claim_id": "CLM-0007",
      "statement": "In 1836 a proposal of marriage was accepted on condition that he take better care of his health; the engagement ended a year later, the family of his fiancée being disturbed by the bad state of his health, as he had been seriously ill in the winter.",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "clinical_interpretation": "Documented frailty and a serious winter illness before the index date.",
      "source_links": [
        {
          "source_id": "SRC-0001",
          "relationship": "supports"
        },
        {
          "source_id": "SRC-0002",
          "relationship": "supports"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    },
    {
      "claim_id": "CLM-0008",
      "statement": "He met the writer George Sand in Paris in 1836; their relationship, which began soon after, lasted nearly ten years.",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "source_links": [
        {
          "source_id": "SRC-0003",
          "relationship": "supports"
        },
        {
          "source_id": "SRC-0002",
          "relationship": "supports"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    },
    {
      "claim_id": "CLM-0009",
      "statement": "In the winter of 1838 to 1839 he stayed on Majorca, arriving in Palma on November 8, 1838. In early December the rented villa became cold and damp, his health worsened, and doctors were called; he wrote on December 3 that he had become \"sick as a dog\" over the previous two weeks. Neighbors fearing an infectious disease led the owner to force them to leave. At the former Carthusian monastery in Valldemossa, from December 15 to February 11, he became gravely ill and showed symptoms of tuberculosis, and for many weeks was too weak to leave the house, yet composed most of the 24 Preludes.",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "clinical_interpretation": "The documented crisis of his chest illness, after the index date.",
      "source_links": [
        {
          "source_id": "SRC-0003",
          "relationship": "supports"
        },
        {
          "source_id": "SRC-0001",
          "relationship": "supports"
        },
        {
          "source_id": "SRC-0002",
          "relationship": "supports"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    },
    {
      "claim_id": "CLM-0010",
      "statement": "On Majorca he suffered long periods of doubt and depression, associated with his illness, and the hostility of local people who feared his illness worsened his state of mind.",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "clinical_interpretation": "Low mood with illness and stigma, in the lay words of the source; not a diagnosis.",
      "source_links": [
        {
          "source_id": "SRC-0003",
          "relationship": "supports"
        }
      ],
      "release_status": "draft",
      "sensitive_content": true
    },
    {
      "claim_id": "CLM-0011",
      "statement": "After Majorca he convalesced in Marseille from late February to May 1839, cared for by a physician, and moved to Nohant in central France still greatly weakened.",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "source_links": [
        {
          "source_id": "SRC-0003",
          "relationship": "supports"
        },
        {
          "source_id": "SRC-0001",
          "relationship": "supports"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    },
    {
      "claim_id": "CLM-0012",
      "statement": "The final parting from George Sand in July 1847 and the loss of Nohant had a devastating effect on his mental and physical state, and he almost gave up composing.",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "source_links": [
        {
          "source_id": "SRC-0001",
          "relationship": "supports"
        },
        {
          "source_id": "SRC-0002",
          "relationship": "context"
        }
      ],
      "release_status": "draft",
      "sensitive_content": true
    },
    {
      "claim_id": "CLM-0013",
      "statement": "From April to November 1848 he toured England and Scotland; the travel, the many performances, and a climate harmful to his lungs further damaged his health, and on November 16, 1848, despite frailty and a fever, he gave his last concert, in London.",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "source_links": [
        {
          "source_id": "SRC-0001",
          "relationship": "supports"
        },
        {
          "source_id": "SRC-0002",
          "relationship": "supports"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    },
    {
      "claim_id": "CLM-0014",
      "statement": "In 1849, after two hemorrhages on June 22, a physician diagnosed tuberculosis in its final stage.",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "clinical_interpretation": "The documented diagnosis made in his lifetime.",
      "source_links": [
        {
          "source_id": "SRC-0002",
          "relationship": "supports"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    },
    {
      "claim_id": "CLM-0015",
      "statement": "He died on October 17, 1849, in his apartment on the Place Vendôme in Paris, of pulmonary tuberculosis according to the Fryderyk Chopin Institute, and was buried in the Père-Lachaise cemetery; at his request his heart was taken to Warsaw and placed in a pillar of the Holy Cross Church.",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "clinical_interpretation": "Recorded as a fact; the modern episode ends in cure.",
      "source_links": [
        {
          "source_id": "SRC-0001",
          "relationship": "supports"
        },
        {
          "source_id": "SRC-0002",
          "relationship": "supports"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    },
    {
      "claim_id": "CLM-0016",
      "statement": "A macroscopic examination of his preserved heart in 2014 found it enlarged and covered with a fibrinous coating with multiple small nodular foci, which the examiners interpreted as tuberculous pericarditis; they concluded that chronic tuberculosis was the most plausible diagnosis and that rapidly progressing tuberculous pericarditis was probably the immediate cause of death. An earlier review of his case history also judged tuberculosis the most probable diagnosis.",
      "evidence_grade": "R",
      "certainty": "probable",
      "clinical_interpretation": "Supports the choice of pulmonary tuberculosis as the modern diagnosis; the heart was examined without tissue or microbiological testing in the cited abstracts.",
      "source_links": [
        {
          "source_id": "SRC-0005",
          "relationship": "supports"
        },
        {
          "source_id": "SRC-0006",
          "relationship": "supports"
        },
        {
          "source_id": "SRC-0007",
          "relationship": "supports"
        },
        {
          "source_id": "SRC-0011",
          "relationship": "supports"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    },
    {
      "claim_id": "CLM-0017",
      "statement": "Cystic fibrosis has been proposed as the cause of his lifelong illness and death; the roster lists a \"probable cystic fibrosis variant.\" The heart examination's authors later argued that the disease was infectious, not genetic.",
      "evidence_grade": "R",
      "certainty": "disputed",
      "clinical_interpretation": "Unproven alternative; addressed in the modern episode with a sweat chloride test and not adopted.",
      "source_links": [
        {
          "source_id": "SRC-0008",
          "relationship": "supports"
        },
        {
          "source_id": "SRC-0006",
          "relationship": "disputes"
        },
        {
          "source_id": "SRC-0012",
          "relationship": "context"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    },
    {
      "claim_id": "CLM-0018",
      "statement": "Alpha-1 antitrypsin deficiency has also been proposed, while noting that the lost autopsy record makes any diagnosis hard to confirm.",
      "evidence_grade": "R",
      "certainty": "disputed",
      "clinical_interpretation": "Unproven alternative; addressed in the modern episode with a serum alpha-1 antitrypsin level and not adopted.",
      "source_links": [
        {
          "source_id": "SRC-0009",
          "relationship": "supports"
        },
        {
          "source_id": "SRC-0006",
          "relationship": "disputes"
        },
        {
          "source_id": "SRC-0011",
          "relationship": "context"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    },
    {
      "claim_id": "CLM-0020",
      "statement": "The same review reports that later in life he had chest pain, hemoptysis, hematemesis, neuralgia, and joint pain, and that exhaustion and breathlessness characterized all his adult life.",
      "evidence_grade": "D",
      "certainty": "probable",
      "clinical_interpretation": "Anchor for the hemoptysis and frailty of the presenting illness; the dated hemoptysis comes after the index date.",
      "source_links": [
        {
          "source_id": "SRC-0010",
          "relationship": "supports"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    },
    {
      "claim_id": "CLM-0019",
      "statement": "Another documentary review proposed that he had dilated cardiomyopathy with heart failure and cirrhosis, rather than tuberculosis, as the cause of death.",
      "evidence_grade": "R",
      "certainty": "disputed",
      "clinical_interpretation": "Alternative interpretation recorded for completeness; not used.",
      "source_links": [
        {
          "source_id": "SRC-0010",
          "relationship": "supports"
        },
        {
          "source_id": "SRC-0007",
          "relationship": "disputes"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    }
  ],
  "sources": [
    {
      "source_id": "SRC-0001",
      "title": "Biography: general outline (Barbara Smoleńska-Zielińska)",
      "publisher": "The Fryderyk Chopin Institute (chopin.pl)",
      "url": "https://chopin.pl/biography_chopin.en.html",
      "source_type": "biography",
      "published": null,
      "accessed": "2026-11-02",
      "rights_note": "Institute biography; facts used with citation."
    },
    {
      "source_id": "SRC-0002",
      "title": "Chopin Fryderyk: a calendar of the composer's life and the list of works",
      "publisher": "Polish Music Information Centre (POLMIC), Polish Composers' Union",
      "url": "https://polmic.pl/en/encyclopedia/subject-entries/c/chopin-fryderyk-en",
      "source_type": "biography",
      "published": null,
      "accessed": "2026-11-02",
      "rights_note": "Encyclopedia entry; facts used with citation."
    },
    {
      "source_id": "SRC-0003",
      "title": "Fryderyk Chopin and George Sand: the trip to Majorca (Bożena Schmid-Adamczyk, Fryderyk Chopin and George Sand Museum, Valldemossa)",
      "publisher": "The Fryderyk Chopin Institute (chopin.pl)",
      "url": "https://www.chopin.pl/majorca.en.html",
      "source_type": "biography",
      "published": null,
      "accessed": "2026-11-02",
      "rights_note": "Institute page by the museum curator; facts and a short quotation from his letter used with citation."
    },
    {
      "source_id": "SRC-0004",
      "title": "Fryderyk Chopin: routes, family",
      "publisher": "Narodowy Instytut Fryderyka Chopina (Great Composers)",
      "url": "https://greatcomposers.nifc.pl/en/chopin/routes/71_family",
      "source_type": "biography",
      "published": null,
      "accessed": "2026-11-02",
      "rights_note": "Institute page; one fact used with citation."
    },
    {
      "source_id": "SRC-0005",
      "title": "Witt M, Szklener A, Kawecki J, et al. A Closer Look at Frederic Chopin's Cause of Death. Am J Med. 2018;131(2):211-212",
      "publisher": "American Journal of Medicine (PubMed 29031593)",
      "url": "https://pubmed.ncbi.nlm.nih.gov/29031593/",
      "source_type": "scholarly",
      "published": "2017-10-12",
      "accessed": "2026-11-02",
      "rights_note": "Bibliographic record; published online October 12, 2017."
    },
    {
      "source_id": "SRC-0006",
      "title": "Witt M, Szklener A, Marchwica W, Dobosz T. Disease not genetic but infectious: multiple tuberculomas and fibrinous pericarditis as symptoms pathognomonic for tuberculosis of Frederic Chopin. J Appl Genet. 2018;59(4):471-473",
      "publisher": "Journal of Applied Genetics (PubMed 30047032)",
      "url": "https://pubmed.ncbi.nlm.nih.gov/30047032/",
      "source_type": "scholarly",
      "published": "2018-07-25",
      "accessed": "2026-11-02",
      "rights_note": "Abstract used with citation."
    },
    {
      "source_id": "SRC-0007",
      "title": "Witt M, Dobosz T. Inheritance vs. infectivity as a mechanism of malady and death of Frederic Chopin. J Appl Genet. 2021;62(4):607-611",
      "publisher": "Journal of Applied Genetics (PubMed 34347238)",
      "url": "https://pubmed.ncbi.nlm.nih.gov/34347238/",
      "source_type": "scholarly",
      "published": "2021-08-04",
      "accessed": "2026-11-02",
      "rights_note": "Open-access abstract used with citation."
    },
    {
      "source_id": "SRC-0008",
      "title": "Majka L, Goździk J, Witt M. Cystic fibrosis: a probable cause of Frédéric Chopin's suffering and death. J Appl Genet. 2003;44(1):77-84",
      "publisher": "Journal of Applied Genetics (PubMed 12590184)",
      "url": "https://pubmed.ncbi.nlm.nih.gov/12590184/",
      "source_type": "scholarly",
      "published": "2003",
      "accessed": "2026-11-02",
      "rights_note": "Abstract used with citation."
    },
    {
      "source_id": "SRC-0009",
      "title": "Eriksson S. Did Chopin suffer of antitrypsin deficiency? Lost autopsy protocol has caused frustration among physicians of our time in their attempts to confirm the diagnosis. Lakartidningen. 2003;100(30-31):2449-54",
      "publisher": "Läkartidningen (PubMed 12914142)",
      "url": "https://pubmed.ncbi.nlm.nih.gov/12914142/",
      "source_type": "scholarly",
      "published": "2003-07-24",
      "accessed": "2026-11-02",
      "rights_note": "Title and bibliographic record only (article in Swedish)."
    },
    {
      "source_id": "SRC-0010",
      "title": "Perciaccante A, Charlier P, Negri C, et al. Did Frédéric Chopin Die From Heart Failure? J Card Fail. 2018;24(5):342-344",
      "publisher": "Journal of Cardiac Failure (PubMed 29597050)",
      "url": "https://pubmed.ncbi.nlm.nih.gov/29597050/",
      "source_type": "scholarly",
      "published": "2018-03-27",
      "accessed": "2026-11-02",
      "rights_note": "Abstract used with citation."
    },
    {
      "source_id": "SRC-0011",
      "title": "Young P, Bernaciak JM, Bruetman JE, Finn BC, Miranda MC. Frederic Chopin (1810-1849), and his disease. Rev Med Chil. 2014;142(4):529-35",
      "publisher": "Revista Médica de Chile (PubMed 25117047)",
      "url": "https://pubmed.ncbi.nlm.nih.gov/25117047/",
      "source_type": "scholarly",
      "published": "2014",
      "accessed": "2026-11-02",
      "rights_note": "Abstract used with citation."
    },
    {
      "source_id": "SRC-0012",
      "title": "HISTMED Master Roster v3",
      "publisher": "The Human Record project",
      "url": "https://humanrecord.example.org/internal/HISTMED_Master_Roster_v3.xlsx",
      "source_type": "other",
      "published": "2026-11-01",
      "accessed": "2026-11-02",
      "rights_note": "Internal source locator; inherited claims remain provisional until corroborated."
    }
  ],
  "synthetic_episode": {
    "calendar_frame": "modern_shifted",
    "index_date": "2026-03-17",
    "index_age": 28,
    "date_shift_policy": "HR-DATE-SHIFT-1",
    "teaching_objective": "Chronic cough with hemoptysis and weight loss in a 28-year-old pianist and piano teacher: chest X-ray and CT, three sputum samples for acid-fast smear, nucleic acid amplification, culture and drug susceptibility, an interferon-gamma release assay, HIV and hepatitis testing, home airborne isolation and same-day public-health reporting; the presenting problem resolved into a diagnosis of drug-susceptible cavitary pulmonary tuberculosis; an honest test of the proposed alternatives for his lifelong chest illness (sweat chloride for cystic fibrosis and a serum alpha-1 antitrypsin level), both normal; treatment with the four-month rifapentine, moxifloxacin, isoniazid, and pyrazinamide regimen by video-observed therapy under the 2022 CDC interim guidance and the ATS/CDC/IDSA guidelines, with eligibility, weight-band dosing, baseline and monitoring tests, and the 119-dose completion rule; release from isolation and return to teaching; a contact investigation led by the health department; care for moderate malnutrition; attention to low mood and the stigma he fears; and an honest record of a missed monthly symptom check.",
    "visit_schedule": [
      {
        "encounter_id": "ENC-001",
        "date": "2026-03-17",
        "purpose": "Three months of cough, two weeks of blood-streaked sputum, night sweats, and weight loss: chest X-ray and CT, sputum samples, blood tests, home airborne isolation, and a report of suspected tuberculosis to the health department"
      },
      {
        "encounter_id": "ENC-002",
        "date": "2026-03-20",
        "purpose": "Results visit: pulmonary tuberculosis confirmed; infectious diseases consultation and the start of the four-month rifapentine-moxifloxacin regimen by video-observed therapy"
      },
      {
        "encounter_id": "ENC-003",
        "date": "2026-04-07",
        "purpose": "Two-and-a-half-week review: release from isolation, return to teaching, liver tests, and tests for cystic fibrosis and alpha-1 antitrypsin deficiency"
      },
      {
        "encounter_id": "ENC-004",
        "date": "2026-05-15",
        "purpose": "End of the eight-week intensive phase: susceptibility results, the two-month sputum culture, and the start of the continuation phase"
      },
      {
        "encounter_id": "ENC-006",
        "date": "2026-06-09",
        "purpose": "Same-day sick visit for a cold with cough during tuberculosis treatment"
      },
      {
        "encounter_id": "ENC-005",
        "date": "2026-07-21",
        "purpose": "End-of-treatment review after 119 doses"
      },
      {
        "encounter_id": "ENC-007",
        "date": "2026-09-15",
        "purpose": "Adult preventive visit"
      }
    ]
  },
  "clinical": {
    "problems": [
      {
        "id": "PRB-001",
        "display": "Cough for about three months, blood-streaked sputum for two weeks, night sweats, and weight loss of about 6 kg in a man of 28, with a right upper lobe cavity on chest X-ray and CT: suspected pulmonary tuberculosis; home airborne isolation and three sputum samples for acid-fast smear, nucleic acid amplification, and culture",
        "status": "draft",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/icd-10-cm",
            "code": "R04.2",
            "display": "Hemoptysis",
            "version": "FY2026",
            "validation_status": "validated",
            "validated_on": "2026-11-02"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0004",
            "CLM-0020"
          ],
          "synthetic_reason": "Synthetic presenting problem linked to his documented chronic cough and hemoptysis; superseded by the diagnosis at the second visit.",
          "author": "The Human Record generator",
          "created": "2026-11-02T15:00:00-05:00"
        },
        "clinical_status": "resolved",
        "verification_status": "confirmed",
        "problem_placement": "active",
        "abatement_date": "2026-03-20"
      },
      {
        "id": "PRB-002",
        "display": "Pulmonary tuberculosis of the right upper lobe, cavitary and sputum smear-positive, confirmed by nucleic acid amplification without rifampin resistance",
        "status": "draft",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/icd-10-cm",
            "code": "A15.0",
            "display": "Tuberculosis of lung",
            "version": "FY2026",
            "validation_status": "validated",
            "validated_on": "2026-11-02"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0004",
            "CLM-0014",
            "CLM-0016"
          ],
          "synthetic_reason": "Synthetic modern coding of his documented tuberculosis, chosen over the disputed genetic and cardiac alternatives; the cavity and all bacteriology are synthetic.",
          "author": "The Human Record generator",
          "created": "2026-11-02T15:00:00-05:00"
        },
        "clinical_status": "active",
        "verification_status": "confirmed",
        "problem_placement": "both_with_link",
        "recorded_date": "2026-03-20"
      },
      {
        "id": "PRB-003",
        "display": "Moderate protein-calorie malnutrition: BMI 16.8, about 11 percent weight loss in three months, and albumin 3.2 g/dL",
        "status": "draft",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/icd-10-cm",
            "code": "E44.0",
            "display": "Moderate protein-calorie malnutrition",
            "version": "FY2026",
            "validation_status": "validated",
            "validated_on": "2026-11-02"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0004",
            "CLM-0007"
          ],
          "synthetic_reason": "Synthetic nutrition diagnosis anchored to his documented frailty and exhaustion.",
          "author": "The Human Record generator",
          "created": "2026-11-02T15:00:00-05:00"
        },
        "clinical_status": "resolved",
        "verification_status": "confirmed",
        "problem_placement": "active",
        "abatement_date": "2026-07-21"
      },
      {
        "id": "PRB-004",
        "display": "Acute viral upper respiratory infection during the continuation phase of tuberculosis treatment; resolved",
        "status": "draft",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/icd-10-cm",
            "code": "J06.9",
            "display": "Acute upper respiratory infection, unspecified",
            "version": "FY2026",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic intercurrent illness chosen to teach how to tell a cold from tuberculosis treatment failure, and moxifloxacin interactions with cold remedies; it does not echo a documented illness.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:00:00-05:00"
        },
        "clinical_status": "resolved",
        "verification_status": "confirmed",
        "problem_placement": "active",
        "recorded_date": "2026-06-09"
      }
    ],
    "medications": [
      {
        "id": "MED-001",
        "display": "Rifapentine 150 mg tablets, eight tablets (1200 mg) daily with food",
        "status": "completed",
        "coding": [
          {
            "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
            "code": "242671",
            "display": "rifapentine 150 MG Oral Tablet",
            "validation_status": "validated",
            "validated_on": "2026-11-02"
          }
        ],
        "dose": {
          "value": 1200,
          "unit": "mg"
        },
        "route": "oral",
        "frequency": {
          "period": 1,
          "period_unit": "d",
          "text": "1200 mg once daily with a meal by video-observed therapy with the health department, seven days a week, for 17 weeks (119 doses)"
        },
        "start_date": "2026-03-20",
        "end_date": "2026-07-16",
        "indication_problem_ids": [
          "PRB-002"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0004",
            "CLM-0014",
            "CLM-0016"
          ],
          "synthetic_reason": "Synthetic four-month rifapentine-moxifloxacin regimen for drug-susceptible pulmonary tuberculosis.",
          "author": "The Human Record generator",
          "created": "2026-11-02T15:00:00-05:00"
        }
      },
      {
        "id": "MED-002",
        "display": "Moxifloxacin 400 mg tablet, one tablet daily",
        "status": "completed",
        "coding": [
          {
            "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
            "code": "311787",
            "display": "moxifloxacin 400 MG Oral Tablet",
            "validation_status": "validated",
            "validated_on": "2026-11-02"
          }
        ],
        "dose": {
          "value": 400,
          "unit": "mg"
        },
        "route": "oral",
        "frequency": {
          "period": 1,
          "period_unit": "d",
          "text": "400 mg once daily with the other drugs by video-observed therapy with the health department, seven days a week, for 17 weeks; no mineral supplements within 4 hours before or 8 hours after"
        },
        "start_date": "2026-03-20",
        "end_date": "2026-07-16",
        "indication_problem_ids": [
          "PRB-002"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0004",
            "CLM-0014",
            "CLM-0016"
          ],
          "synthetic_reason": "Synthetic four-month regimen.",
          "author": "The Human Record generator",
          "created": "2026-11-02T15:00:00-05:00"
        }
      },
      {
        "id": "MED-003",
        "display": "Isoniazid 300 mg tablet, one tablet daily",
        "status": "completed",
        "coding": [
          {
            "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
            "code": "197832",
            "display": "isoniazid 300 MG Oral Tablet",
            "validation_status": "validated",
            "validated_on": "2026-11-02"
          }
        ],
        "dose": {
          "value": 300,
          "unit": "mg"
        },
        "route": "oral",
        "frequency": {
          "period": 1,
          "period_unit": "d",
          "text": "300 mg once daily by video-observed therapy with the health department, seven days a week, for 17 weeks"
        },
        "start_date": "2026-03-20",
        "end_date": "2026-07-16",
        "indication_problem_ids": [
          "PRB-002"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0004",
            "CLM-0014",
            "CLM-0016"
          ],
          "synthetic_reason": "Synthetic four-month regimen.",
          "author": "The Human Record generator",
          "created": "2026-11-02T15:00:00-05:00"
        }
      },
      {
        "id": "MED-004",
        "display": "Pyrazinamide 500 mg tablets, two tablets (1000 mg) daily",
        "status": "completed",
        "coding": [
          {
            "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
            "code": "198181",
            "display": "pyrazinamide 500 MG Oral Tablet",
            "validation_status": "validated",
            "validated_on": "2026-11-02"
          }
        ],
        "dose": {
          "value": 1000,
          "unit": "mg"
        },
        "route": "oral",
        "frequency": {
          "period": 1,
          "period_unit": "d",
          "text": "1000 mg once daily by video-observed therapy with the health department, seven days a week, for the eight-week intensive phase (weight band 40 to under 55 kg)"
        },
        "start_date": "2026-03-20",
        "end_date": "2026-05-14",
        "indication_problem_ids": [
          "PRB-002"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0004",
            "CLM-0014",
            "CLM-0016"
          ],
          "synthetic_reason": "Synthetic weight-band dose for the intensive phase.",
          "author": "The Human Record generator",
          "created": "2026-11-02T15:00:00-05:00"
        }
      },
      {
        "id": "MED-005",
        "display": "Vitamin B6 (pyridoxine) 50 mg tablet, one tablet daily",
        "status": "completed",
        "coding": [
          {
            "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
            "code": "639566",
            "display": "vitamin B6 50 MG Oral Tablet",
            "validation_status": "validated",
            "validated_on": "2026-11-02"
          }
        ],
        "dose": {
          "value": 50,
          "unit": "mg"
        },
        "route": "oral",
        "frequency": {
          "period": 1,
          "period_unit": "d",
          "text": "50 mg once daily with isoniazid"
        },
        "start_date": "2026-03-20",
        "end_date": "2026-07-16",
        "indication_problem_ids": [
          "PRB-002"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic neuropathy prevention with isoniazid in a man who is undernourished.",
          "author": "The Human Record generator",
          "created": "2026-11-02T15:00:00-05:00"
        }
      }
    ],
    "allergies": [
      {
        "id": "ALG-001",
        "display": "No known allergy",
        "status": "active",
        "assertion": "no_known_allergy",
        "substance": {
          "system": "http://snomed.info/sct",
          "code": "716186003",
          "display": "No known allergy"
        },
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic allergy assertion for EHR completeness; not a historical assertion.",
          "author": "The Human Record generator",
          "created": "2026-11-02T15:00:00-05:00"
        }
      }
    ],
    "observations": [
      {
        "id": "OBS-HGB-V1",
        "display": "Hemoglobin [Mass/volume] in Blood",
        "label": "Hemoglobin",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-03-17",
        "value": 12.1,
        "unit": "g/dL",
        "reference_range": {
          "low": 13.2,
          "high": 16.6
        },
        "interpretation": "L",
        "panel": {
          "code": "58410-2",
          "display": "CBC panel - Blood by Automated count"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "718-7",
            "display": "Hemoglobin [Mass/volume] in Blood",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-02"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0004",
            "CLM-0020"
          ],
          "synthetic_reason": "Synthetic baseline result before tuberculosis treatment.",
          "author": "The Human Record generator",
          "created": "2026-11-02T15:00:00-05:00"
        }
      },
      {
        "id": "OBS-WBC-V1",
        "display": "Leukocytes [#/volume] in Blood by Automated count",
        "label": "White cell count",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-03-17",
        "value": 9.6,
        "unit": "10*3/uL",
        "reference_range": {
          "low": 4.0,
          "high": 11.0
        },
        "interpretation": "N",
        "panel": {
          "code": "58410-2",
          "display": "CBC panel - Blood by Automated count"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "6690-2",
            "display": "Leukocytes [#/volume] in Blood by Automated count",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-02"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0004",
            "CLM-0020"
          ],
          "synthetic_reason": "Synthetic baseline result before tuberculosis treatment.",
          "author": "The Human Record generator",
          "created": "2026-11-02T15:00:00-05:00"
        }
      },
      {
        "id": "OBS-PLT-V1",
        "display": "Platelets [#/volume] in Blood by Automated count",
        "label": "Platelets",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-03-17",
        "value": 442,
        "unit": "10*3/uL",
        "reference_range": {
          "low": 150,
          "high": 400
        },
        "interpretation": "H",
        "panel": {
          "code": "58410-2",
          "display": "CBC panel - Blood by Automated count"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "777-3",
            "display": "Platelets [#/volume] in Blood by Automated count",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-02"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0004",
            "CLM-0020"
          ],
          "synthetic_reason": "Synthetic baseline result before tuberculosis treatment.",
          "author": "The Human Record generator",
          "created": "2026-11-02T15:00:00-05:00"
        }
      },
      {
        "id": "OBS-ALT-V1",
        "display": "Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
        "label": "ALT",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-03-17",
        "value": 18,
        "unit": "U/L",
        "reference_range": {
          "low": 7,
          "high": 56
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "1742-6",
            "display": "Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-02"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0004",
            "CLM-0020"
          ],
          "synthetic_reason": "Synthetic baseline result before tuberculosis treatment.",
          "author": "The Human Record generator",
          "created": "2026-11-02T15:00:00-05:00"
        }
      },
      {
        "id": "OBS-AST-V1",
        "display": "Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
        "label": "AST",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-03-17",
        "value": 24,
        "unit": "U/L",
        "reference_range": {
          "low": 10,
          "high": 40
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "1920-8",
            "display": "Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-02"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0004",
            "CLM-0020"
          ],
          "synthetic_reason": "Synthetic baseline result before tuberculosis treatment.",
          "author": "The Human Record generator",
          "created": "2026-11-02T15:00:00-05:00"
        }
      },
      {
        "id": "OBS-TBIL-V1",
        "display": "Bilirubin.total [Mass/volume] in Serum or Plasma",
        "label": "Total bilirubin",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-03-17",
        "value": 0.5,
        "unit": "mg/dL",
        "reference_range": {
          "low": 0.1,
          "high": 1.2
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "1975-2",
            "display": "Bilirubin.total [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-02"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0004",
            "CLM-0020"
          ],
          "synthetic_reason": "Synthetic baseline result before tuberculosis treatment.",
          "author": "The Human Record generator",
          "created": "2026-11-02T15:00:00-05:00"
        }
      },
      {
        "id": "OBS-ALP-V1",
        "display": "Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma",
        "label": "Alkaline phosphatase",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-03-17",
        "value": 84,
        "unit": "U/L",
        "reference_range": {
          "low": 40,
          "high": 129
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "6768-6",
            "display": "Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-02"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0004",
            "CLM-0020"
          ],
          "synthetic_reason": "Synthetic baseline result before tuberculosis treatment.",
          "author": "The Human Record generator",
          "created": "2026-11-02T15:00:00-05:00"
        }
      },
      {
        "id": "OBS-ALB-V1",
        "display": "Albumin [Mass/volume] in Serum or Plasma",
        "label": "Albumin",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-03-17",
        "value": 3.2,
        "unit": "g/dL",
        "reference_range": {
          "low": 3.5,
          "high": 5.0
        },
        "interpretation": "L",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "1751-7",
            "display": "Albumin [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-02"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0004",
            "CLM-0020"
          ],
          "synthetic_reason": "Synthetic baseline result before tuberculosis treatment.",
          "author": "The Human Record generator",
          "created": "2026-11-02T15:00:00-05:00"
        }
      },
      {
        "id": "OBS-CR-V1",
        "display": "Creatinine [Mass/volume] in Serum or Plasma",
        "label": "Creatinine",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-03-17",
        "value": 0.78,
        "unit": "mg/dL",
        "reference_range": {
          "low": 0.74,
          "high": 1.35
        },
        "interpretation": "N",
        "panel": {
          "code": "51990-0",
          "display": "Basic metabolic panel - Blood"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2160-0",
            "display": "Creatinine [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-02"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0004",
            "CLM-0020"
          ],
          "synthetic_reason": "Synthetic baseline result before tuberculosis treatment.",
          "author": "The Human Record generator",
          "created": "2026-11-02T15:00:00-05:00"
        }
      },
      {
        "id": "OBS-EGFR-V1",
        "display": "Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M",
        "label": "eGFR",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-03-17",
        "value": 125,
        "unit": "mL/min/{1.73_m2}",
        "reference_range": {
          "low": 60
        },
        "interpretation": "N",
        "panel": {
          "code": "51990-0",
          "display": "Basic metabolic panel - Blood"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "98979-8",
            "display": "Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-02"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0004",
            "CLM-0020"
          ],
          "synthetic_reason": "Synthetic baseline result before tuberculosis treatment.",
          "author": "The Human Record generator",
          "created": "2026-11-02T15:00:00-05:00"
        }
      },
      {
        "id": "OBS-GLU-V1",
        "display": "Glucose [Mass/volume] in Serum or Plasma",
        "label": "Glucose",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-03-17",
        "value": 86,
        "unit": "mg/dL",
        "reference_range": {
          "low": 70,
          "high": 99
        },
        "interpretation": "N",
        "panel": {
          "code": "51990-0",
          "display": "Basic metabolic panel - Blood"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2345-7",
            "display": "Glucose [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-02"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0004",
            "CLM-0020"
          ],
          "synthetic_reason": "Synthetic baseline result before tuberculosis treatment.",
          "author": "The Human Record generator",
          "created": "2026-11-02T15:00:00-05:00"
        }
      },
      {
        "id": "OBS-K-V1",
        "display": "Potassium [Moles/volume] in Serum or Plasma",
        "label": "Potassium",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-03-17",
        "value": 4.0,
        "unit": "mmol/L",
        "reference_range": {
          "low": 3.5,
          "high": 5.1
        },
        "interpretation": "N",
        "panel": {
          "code": "51990-0",
          "display": "Basic metabolic panel - Blood"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2823-3",
            "display": "Potassium [Moles/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-02"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0004",
            "CLM-0020"
          ],
          "synthetic_reason": "Synthetic baseline result before tuberculosis treatment.",
          "author": "The Human Record generator",
          "created": "2026-11-02T15:00:00-05:00"
        }
      },
      {
        "id": "OBS-CA-V1",
        "display": "Calcium [Mass/volume] in Serum or Plasma",
        "label": "Calcium",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-03-17",
        "value": 9.0,
        "unit": "mg/dL",
        "reference_range": {
          "low": 8.6,
          "high": 10.3
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "17861-6",
            "display": "Calcium [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-02"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0004",
            "CLM-0020"
          ],
          "synthetic_reason": "Synthetic baseline result before tuberculosis treatment.",
          "author": "The Human Record generator",
          "created": "2026-11-02T15:00:00-05:00"
        }
      },
      {
        "id": "OBS-MG-V1",
        "display": "Magnesium [Mass/volume] in Serum or Plasma",
        "label": "Magnesium",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-03-17",
        "value": 2.0,
        "unit": "mg/dL",
        "reference_range": {
          "low": 1.7,
          "high": 2.2
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "19123-9",
            "display": "Magnesium [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-02"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0004",
            "CLM-0020"
          ],
          "synthetic_reason": "Synthetic baseline result before tuberculosis treatment.",
          "author": "The Human Record generator",
          "created": "2026-11-02T15:00:00-05:00"
        }
      },
      {
        "id": "OBS-PHQ9-V1",
        "display": "Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]",
        "label": "PHQ-9",
        "status": "final",
        "effective_date": "2026-03-17",
        "value": 7,
        "unit": "{score}",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "44261-6",
            "display": "Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-02"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0010"
          ],
          "synthetic_reason": "Synthetic depression screen: low mood, poor sleep from night sweats, and worry about his students; item 9 scored 0.",
          "author": "The Human Record generator",
          "created": "2026-11-02T15:00:00-05:00"
        }
      },
      {
        "id": "OBS-AUDITC-V1",
        "display": "Total score [AUDIT-C]",
        "label": "AUDIT-C",
        "status": "final",
        "effective_date": "2026-03-17",
        "value": 2,
        "unit": "{score}",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "75626-2",
            "display": "Total score [AUDIT-C]",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-02"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic alcohol screen: a glass of wine with dinner a few times a week.",
          "author": "The Human Record generator",
          "created": "2026-11-02T15:00:00-05:00"
        }
      },
      {
        "id": "OBS-ALT-V3",
        "display": "Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
        "label": "ALT",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-04-07",
        "value": 34,
        "unit": "U/L",
        "reference_range": {
          "low": 7,
          "high": 56
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "1742-6",
            "display": "Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-02"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0004",
            "CLM-0014",
            "CLM-0016"
          ],
          "synthetic_reason": "Synthetic two-and-a-half-week liver check on rifapentine, isoniazid, pyrazinamide, and moxifloxacin, done because of his low weight and albumin.",
          "author": "The Human Record generator",
          "created": "2026-11-02T15:00:00-05:00"
        }
      },
      {
        "id": "OBS-AST-V3",
        "display": "Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
        "label": "AST",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-04-07",
        "value": 31,
        "unit": "U/L",
        "reference_range": {
          "low": 10,
          "high": 40
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "1920-8",
            "display": "Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-02"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0004",
            "CLM-0014",
            "CLM-0016"
          ],
          "synthetic_reason": "Synthetic two-and-a-half-week liver check on rifapentine, isoniazid, pyrazinamide, and moxifloxacin, done because of his low weight and albumin.",
          "author": "The Human Record generator",
          "created": "2026-11-02T15:00:00-05:00"
        }
      },
      {
        "id": "OBS-TBIL-V3",
        "display": "Bilirubin.total [Mass/volume] in Serum or Plasma",
        "label": "Total bilirubin",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-04-07",
        "value": 0.8,
        "unit": "mg/dL",
        "reference_range": {
          "low": 0.1,
          "high": 1.2
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "1975-2",
            "display": "Bilirubin.total [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-02"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0004",
            "CLM-0014",
            "CLM-0016"
          ],
          "synthetic_reason": "Synthetic two-and-a-half-week liver check on rifapentine, isoniazid, pyrazinamide, and moxifloxacin, done because of his low weight and albumin.",
          "author": "The Human Record generator",
          "created": "2026-11-02T15:00:00-05:00"
        }
      },
      {
        "id": "OBS-SWCL-V3",
        "display": "Chloride [Moles/volume] in Sweat",
        "label": "Sweat chloride",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-04-07",
        "value": 18,
        "unit": "mmol/L",
        "reference_range": {
          "high": 29
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2077-6",
            "display": "Chloride [Moles/volume] in Sweat",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-02"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0017",
            "CLM-0018"
          ],
          "synthetic_reason": "Synthetic sweat chloride by quantitative pilocarpine iontophoresis, done once he was out of isolation; below 30, so cystic fibrosis is unlikely.",
          "author": "The Human Record generator",
          "created": "2026-11-02T15:00:00-05:00"
        }
      },
      {
        "id": "OBS-A1AT-V3",
        "display": "Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma by Nephelometry",
        "label": "Alpha-1 antitrypsin",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-04-07",
        "value": 142,
        "unit": "mg/dL",
        "reference_range": {
          "low": 100,
          "high": 190
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "6771-0",
            "display": "Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma by Nephelometry",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-02"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0017",
            "CLM-0018"
          ],
          "synthetic_reason": "Synthetic serum alpha-1 antitrypsin level; normal, so severe deficiency is excluded.",
          "author": "The Human Record generator",
          "created": "2026-11-02T15:00:00-05:00"
        }
      },
      {
        "id": "OBS-ALT-V4",
        "display": "Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
        "label": "ALT",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-05-15",
        "value": 29,
        "unit": "U/L",
        "reference_range": {
          "low": 7,
          "high": 56
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "1742-6",
            "display": "Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-02"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0004",
            "CLM-0014",
            "CLM-0016"
          ],
          "synthetic_reason": "Synthetic end-of-intensive-phase result.",
          "author": "The Human Record generator",
          "created": "2026-11-02T15:00:00-05:00"
        }
      },
      {
        "id": "OBS-AST-V4",
        "display": "Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
        "label": "AST",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-05-15",
        "value": 27,
        "unit": "U/L",
        "reference_range": {
          "low": 10,
          "high": 40
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "1920-8",
            "display": "Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-02"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0004",
            "CLM-0014",
            "CLM-0016"
          ],
          "synthetic_reason": "Synthetic end-of-intensive-phase result.",
          "author": "The Human Record generator",
          "created": "2026-11-02T15:00:00-05:00"
        }
      },
      {
        "id": "OBS-TBIL-V4",
        "display": "Bilirubin.total [Mass/volume] in Serum or Plasma",
        "label": "Total bilirubin",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-05-15",
        "value": 0.6,
        "unit": "mg/dL",
        "reference_range": {
          "low": 0.1,
          "high": 1.2
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "1975-2",
            "display": "Bilirubin.total [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-02"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0004",
            "CLM-0014",
            "CLM-0016"
          ],
          "synthetic_reason": "Synthetic end-of-intensive-phase result.",
          "author": "The Human Record generator",
          "created": "2026-11-02T15:00:00-05:00"
        }
      },
      {
        "id": "OBS-HGB-V4",
        "display": "Hemoglobin [Mass/volume] in Blood",
        "label": "Hemoglobin",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-05-15",
        "value": 13.0,
        "unit": "g/dL",
        "reference_range": {
          "low": 13.2,
          "high": 16.6
        },
        "interpretation": "L",
        "panel": {
          "code": "58410-2",
          "display": "CBC panel - Blood by Automated count"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "718-7",
            "display": "Hemoglobin [Mass/volume] in Blood",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-02"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0004",
            "CLM-0014",
            "CLM-0016"
          ],
          "synthetic_reason": "Synthetic end-of-intensive-phase result.",
          "author": "The Human Record generator",
          "created": "2026-11-02T15:00:00-05:00"
        }
      },
      {
        "id": "OBS-PHQ9-V4",
        "display": "Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]",
        "label": "PHQ-9",
        "status": "final",
        "effective_date": "2026-05-15",
        "value": 4,
        "unit": "{score}",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "44261-6",
            "display": "Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-02"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic PHQ-9; item 9 scored 0.",
          "author": "The Human Record generator",
          "created": "2026-11-02T15:00:00-05:00"
        }
      },
      {
        "id": "OBS-HGB-V5",
        "display": "Hemoglobin [Mass/volume] in Blood",
        "label": "Hemoglobin",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-07-21",
        "value": 14.1,
        "unit": "g/dL",
        "reference_range": {
          "low": 13.2,
          "high": 16.6
        },
        "interpretation": "N",
        "panel": {
          "code": "58410-2",
          "display": "CBC panel - Blood by Automated count"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "718-7",
            "display": "Hemoglobin [Mass/volume] in Blood",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-02"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0004",
            "CLM-0014",
            "CLM-0016"
          ],
          "synthetic_reason": "Synthetic end-of-treatment result.",
          "author": "The Human Record generator",
          "created": "2026-11-02T15:00:00-05:00"
        }
      },
      {
        "id": "OBS-ALB-V5",
        "display": "Albumin [Mass/volume] in Serum or Plasma",
        "label": "Albumin",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-07-21",
        "value": 4.0,
        "unit": "g/dL",
        "reference_range": {
          "low": 3.5,
          "high": 5.0
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "1751-7",
            "display": "Albumin [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-02"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0004",
            "CLM-0014",
            "CLM-0016"
          ],
          "synthetic_reason": "Synthetic end-of-treatment result.",
          "author": "The Human Record generator",
          "created": "2026-11-02T15:00:00-05:00"
        }
      },
      {
        "id": "OBS-ALT-V5",
        "display": "Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
        "label": "ALT",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-07-21",
        "value": 22,
        "unit": "U/L",
        "reference_range": {
          "low": 7,
          "high": 56
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "1742-6",
            "display": "Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-02"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0004",
            "CLM-0014",
            "CLM-0016"
          ],
          "synthetic_reason": "Synthetic end-of-treatment result.",
          "author": "The Human Record generator",
          "created": "2026-11-02T15:00:00-05:00"
        }
      },
      {
        "id": "OBS-PHQ9-V5",
        "display": "Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]",
        "label": "PHQ-9",
        "status": "final",
        "effective_date": "2026-07-21",
        "value": 3,
        "unit": "{score}",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "44261-6",
            "display": "Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-02"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic end-of-treatment mood screen; item 9 scored 0.",
          "author": "The Human Record generator",
          "created": "2026-11-02T15:00:00-05:00"
        }
      },
      {
        "id": "OBS-PHQ2-PREV",
        "display": "Patient Health Questionnaire 2 item (PHQ-2) total score [Reported]",
        "label": "PHQ-2",
        "status": "final",
        "effective_date": "2026-09-15",
        "value": 0,
        "unit": "{score}",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "55758-7",
            "display": "Patient Health Questionnaire 2 item (PHQ-2) total score [Reported]",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic depression screen at the preventive visit.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:00:00-05:00"
        }
      },
      {
        "id": "OBS-AUDITC-PREV",
        "display": "Total score [AUDIT-C]",
        "label": "AUDIT-C",
        "status": "final",
        "effective_date": "2026-09-15",
        "value": 2,
        "unit": "{score}",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "75626-2",
            "display": "Total score [AUDIT-C]",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic yearly alcohol screen.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:00:00-05:00"
        }
      }
    ],
    "procedures": [
      {
        "id": "PROC-001",
        "display": "Chest X-ray, two views: right upper lobe consolidation with a 2.5 cm thick-walled cavity and patchy opacities in the left upper zone; no effusion",
        "status": "completed",
        "coding": [
          {
            "system": "http://snomed.info/sct",
            "code": "399208008",
            "display": "Plain X-ray of chest",
            "validation_status": "validated",
            "validated_on": "2026-11-02"
          }
        ],
        "period": {
          "start": "2026-03-17",
          "end": "2026-03-17"
        },
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0004",
            "CLM-0020"
          ],
          "synthetic_reason": "Synthetic diagnostic chest X-ray.",
          "author": "The Human Record generator",
          "created": "2026-11-02T15:00:00-05:00"
        }
      },
      {
        "id": "PROC-002",
        "display": "CT of the chest without contrast: a 2.5 cm thick-walled cavity in the apical segment of the right upper lobe with surrounding consolidation and tree-in-bud nodules in both upper lobes; no bronchiectasis, no emphysema, no enlarged lymph nodes, no effusion",
        "status": "completed",
        "coding": [
          {
            "system": "http://snomed.info/sct",
            "code": "169069000",
            "display": "CT of chest",
            "validation_status": "validated",
            "validated_on": "2026-11-02"
          }
        ],
        "period": {
          "start": "2026-03-17",
          "end": "2026-03-17"
        },
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0004",
            "CLM-0020"
          ],
          "synthetic_reason": "Synthetic CT; the absence of bronchiectasis and emphysema bears on the cystic fibrosis and alpha-1 antitrypsin alternatives.",
          "author": "The Human Record generator",
          "created": "2026-11-02T15:00:00-05:00"
        }
      },
      {
        "id": "PROC-003",
        "display": "Chest X-ray, two views, at the end of treatment: cavity closed, with a small area of right upper lobe scarring; kept as the baseline for any future comparison",
        "status": "completed",
        "coding": [
          {
            "system": "http://snomed.info/sct",
            "code": "399208008",
            "display": "Plain X-ray of chest",
            "validation_status": "validated",
            "validated_on": "2026-11-02"
          }
        ],
        "period": {
          "start": "2026-07-21",
          "end": "2026-07-21"
        },
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0004",
            "CLM-0014",
            "CLM-0016"
          ],
          "synthetic_reason": "Synthetic end-of-treatment chest X-ray.",
          "author": "The Human Record generator",
          "created": "2026-11-02T15:00:00-05:00"
        }
      }
    ],
    "immunizations": [
      {
        "id": "IMM-001",
        "display": "Tetanus, diphtheria, and pertussis (Tdap) booster",
        "status": "completed",
        "date": "2023-10-04",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/cvx",
            "code": "115",
            "display": "Tdap",
            "validation_status": "validated",
            "validated_on": "2026-11-02"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic adult immunization history in the modern frame; not a historical assertion.",
          "author": "The Human Record generator",
          "created": "2026-11-02T15:00:00-05:00"
        }
      },
      {
        "id": "IMM-002",
        "display": "Influenza vaccine, 2026-2027 season",
        "status": "completed",
        "date": "2026-09-15",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/cvx",
            "code": "140",
            "display": "Influenza, split virus, trivalent, PF",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic yearly influenza vaccination.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:00:00-05:00"
        }
      }
    ],
    "family_history": [
      {
        "id": "FH-001",
        "relationship": {
          "system": "http://terminology.hl7.org/CodeSystem/v3-RoleCode",
          "code": "SIS",
          "display": "sister"
        },
        "condition": "Tuberculosis; died of it in 1827",
        "provenance": {
          "evidence_grade": "D",
          "claim_ids": [
            "CLM-0003"
          ],
          "synthetic_reason": null,
          "author": "The Human Record generator",
          "created": "2026-11-02T15:00:00-05:00"
        }
      }
    ],
    "past_medical_history": [
      {
        "id": "PMH-001",
        "display": "Recurrent episodes of cough, fever, headaches, and swollen lymph nodes in his teens",
        "historical_date": {
          "iso": "1820",
          "display": "1820s",
          "precision": "decade",
          "calendar": "gregorian"
        },
        "provenance": {
          "evidence_grade": "D",
          "claim_ids": [
            "CLM-0004"
          ],
          "synthetic_reason": null,
          "author": "The Human Record generator",
          "created": "2026-11-02T15:00:00-05:00"
        }
      },
      {
        "id": "PMH-002",
        "display": "Serious illness; cause not recorded in the cited source",
        "historical_date": {
          "iso": "1837",
          "display": "winter of 1836 to 1837",
          "precision": "year",
          "calendar": "gregorian"
        },
        "provenance": {
          "evidence_grade": "D",
          "claim_ids": [
            "CLM-0007"
          ],
          "synthetic_reason": null,
          "author": "The Human Record generator",
          "created": "2026-11-02T15:00:00-05:00"
        }
      }
    ],
    "encounters": [
      {
        "id": "ENC-001",
        "display": "Three months of cough, two weeks of blood-streaked sputum, night sweats, and weight loss: chest X-ray and CT, sputum samples, blood tests, home airborne isolation, and a report of suspected tuberculosis to the health department",
        "status": "finished",
        "date": "2026-03-17",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic modern EHR encounter.",
          "author": "The Human Record generator",
          "created": "2026-11-02T15:00:00-05:00"
        }
      },
      {
        "id": "ENC-002",
        "display": "Results visit: pulmonary tuberculosis confirmed; infectious diseases consultation and the start of the four-month rifapentine-moxifloxacin regimen by video-observed therapy",
        "status": "finished",
        "date": "2026-03-20",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic modern EHR encounter.",
          "author": "The Human Record generator",
          "created": "2026-11-02T15:00:00-05:00"
        },
        "visit_type": "chronic_care",
        "type_coding": {
          "system": "http://snomed.info/sct",
          "code": "390906007",
          "display": "Follow-up encounter",
          "validation_status": "validated",
          "validated_on": "2026-11-04"
        },
        "documentation": {
          "chief_complaint": "Results visit: tuberculosis confirmed; infectious diseases consultation and start of treatment",
          "hpi": {
            "narrative": "Mr. Chopin returns three days after his first visit, masked and seen in an airborne infection isolation room, for his results; Dr. Kowalczyk-Grant of infectious diseases sees him the same morning. He has stayed at home with no students or visitors, and his lessons have moved online. His cough and night sweats are unchanged, and he has coughed up streaks of blood once since the first visit. His three sputum smears show acid-fast bacilli (2+, 2+, and 1+), and the nucleic acid amplification test on the first sample detected Mycobacterium tuberculosis complex with no rifampin resistance; molecular tests for isoniazid and fluoroquinolone resistance and the cultures are pending. The interferon-gamma release assay is positive, HIV is negative, hepatitis B surface antigen and core antibody are negative with surface antibody positive from vaccination, and hepatitis C antibody is negative. He was relieved to have a name for the illness and asked how long treatment lasts and when he can teach again. After the four-month and six-month regimens were explained, he chose the four-month regimen and took his first observed dose with a meal in the clinic.",
            "elements": [
              {
                "label": "Results",
                "value": "Smears 2+, 2+, 1+; amplification test positive without rifampin resistance; IGRA positive; HIV negative; hepatitis B immune; hepatitis C negative"
              },
              {
                "label": "Symptoms",
                "value": "Cough, one more streak of blood, night sweats"
              },
              {
                "label": "Decision",
                "value": "Four-month rifapentine-moxifloxacin regimen, first dose today"
              },
              {
                "label": "Isolation",
                "value": "At home; lessons online"
              }
            ]
          },
          "ros": [
            {
              "system": "Respiratory",
              "status": "positive",
              "finding": "Cough with morning sputum; one more streak of blood since the first visit; no breathlessness at rest"
            },
            {
              "system": "Constitutional",
              "status": "positive",
              "finding": "Night sweats and evening fevers; poor appetite"
            },
            {
              "system": "Musculoskeletal",
              "status": "negative",
              "finding": "No tendon or joint pain"
            },
            {
              "system": "Neurological",
              "status": "negative",
              "finding": "No numbness or tingling; fine finger movements normal"
            },
            {
              "system": "Psychiatric",
              "status": "positive",
              "finding": "Anxious and low, but relieved to know the diagnosis; no thoughts of suicide or self-harm"
            }
          ],
          "exam": [
            {
              "system": "General",
              "finding": "Thin and tired; weight 48.4 kg; temperature 37.6 °C, pulse 98; seen in an airborne infection isolation room with a respirator"
            },
            {
              "system": "Respiratory",
              "finding": "Coarse crackles and bronchial breathing over the right upper zone; fine crackles at the left apex"
            },
            {
              "system": "Abdomen",
              "finding": "Soft; liver not enlarged"
            },
            {
              "system": "Musculoskeletal",
              "finding": "Achilles and wrist tendons non-tender, as a baseline before moxifloxacin"
            },
            {
              "system": "Neurological",
              "finding": "Normal light touch and vibration in the fingers and feet, as a baseline before isoniazid"
            }
          ],
          "assessment_plan": [
            {
              "problem_id": "PRB-002",
              "display": "Pulmonary tuberculosis, cavitary, smear-positive",
              "assessment": "Confirmed today, replacing the presenting problem of cough, hemoptysis, and weight loss. No rifampin resistance. He meets the criteria for the four-month regimen: over 12 years old, weight 48.4 kg (at least 40 kg), pulmonary disease only, HIV negative, no prolonged QT history and no QT-prolonging or interacting medicines, normal potassium (4.0), magnesium (2.0), liver tests, and creatinine, no earlier tuberculosis treatment, and specimens sent for susceptibility testing before the first dose. Dr. Kowalczyk-Grant agrees",
              "plan": [
                "Rifapentine 1200 mg, moxifloxacin 400 mg, isoniazid 300 mg, and pyrazinamide 1000 mg daily with food for eight weeks, then rifapentine, moxifloxacin, and isoniazid for nine weeks, with pyridoxine 50 mg, by video-observed therapy seven days a week",
                "Three sputum smears in the third week for the release decision; then monthly sputum until two cultures are negative",
                "Liver tests in two to three weeks because of his low weight and albumin; stop the doses and call the same day for yellow eyes, dark urine, vomiting, or abdominal pain",
                "Stop moxifloxacin and call for tendon pain; report numbness or tingling in his fingers",
                "No mineral supplements, antacids, or zinc products within four hours before or eight hours after the dose"
              ]
            },
            {
              "problem_id": "PRB-003",
              "display": "Moderate protein-calorie malnutrition",
              "assessment": "BMI 16.7 today. Appetite should return as the infection comes under control",
              "plan": [
                "First dietitian visit by video this week; supplement drinks in the afternoon and evening, well away from the morning dose"
              ]
            }
          ],
          "monitoring": [
            {
              "domain": "examination",
              "measure": "Symptom review: cough, sputum, hemoptysis, fever, night sweats",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "Cough, one more streak of blood, night sweats; no improvement yet before treatment",
              "guideline_ids": [
                "GL-CDC-4MO-2022",
                "GL-ATS-TB-2016"
              ]
            },
            {
              "domain": "examination",
              "measure": "Weight, with the pyrazinamide dose checked against the weight band",
              "cadence": "Monthly",
              "status": "completed_today",
              "detail": "48.4 kg: pyrazinamide 1000 mg for the 40 to under 55 kg band",
              "guideline_ids": [
                "GL-CDC-4MO-2022",
                "GL-ATS-TB-2016"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Adverse effects: hepatitis symptoms, tendon pain, numbness or tingling, rash, nausea, orange body fluids",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "Baseline tendon and nerve examination normal; warning symptoms explained",
              "guideline_ids": [
                "GL-CDC-4MO-2022",
                "GL-ATS-HEPATOTOX-2006"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Liver tests (ALT, AST, bilirubin)",
              "cadence": "Baseline; repeat for symptoms or risk factors (here at two to three weeks, for low weight and albumin)",
              "status": "up_to_date",
              "detail": "Baseline ALT 18, AST 24, bilirubin 0.5, all normal; repeat ordered for the next visit",
              "guideline_ids": [
                "GL-CDC-4MO-2022",
                "GL-ATS-HEPATOTOX-2006"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Potassium, calcium, magnesium, platelets, creatinine",
              "cadence": "Baseline, then as indicated",
              "status": "up_to_date",
              "detail": "Baseline potassium 4.0, calcium 9.0, magnesium 2.0, platelets 442 (raised with inflammation), creatinine 0.78",
              "guideline_ids": [
                "GL-CDC-4MO-2022",
                "GL-ATS-TB-2016"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Electrocardiogram (QT interval)",
              "cadence": "Not routine; only if clinically indicated",
              "status": "not_indicated",
              "detail": "No QT history, no QT-prolonging medicines, normal potassium and magnesium",
              "guideline_ids": [
                "GL-CDC-4MO-2022",
                "GL-ATS-TB-2016"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Sputum acid-fast smear and culture",
              "cadence": "Baseline, then monthly until two consecutive cultures are negative",
              "status": "completed_today",
              "detail": "Three baseline smears 2+, 2+, 1+; cultures pending",
              "guideline_ids": [
                "GL-CDC-4MO-2022",
                "GL-ATS-TB-2016"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Nucleic acid amplification test with rifampin resistance",
              "cadence": "At baseline",
              "status": "completed_today",
              "detail": "Mycobacterium tuberculosis complex detected; rifampin resistance not detected",
              "guideline_ids": [
                "GL-CDC-4MO-2022",
                "GL-ATS-TB-2016"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Rapid molecular testing for isoniazid and fluoroquinolone resistance",
              "cadence": "At baseline",
              "status": "ordered",
              "detail": "Sent on the first sample; pending",
              "guideline_ids": [
                "GL-CDC-4MO-2022",
                "GL-ATS-TB-2016"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Phenotypic susceptibility (rifampin, isoniazid, pyrazinamide, moxifloxacin)",
              "cadence": "At baseline",
              "status": "ordered",
              "detail": "On the culture isolate when it grows",
              "guideline_ids": [
                "GL-CDC-4MO-2022",
                "GL-ATS-TB-2016"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Interferon-gamma release assay",
              "cadence": "At baseline",
              "status": "completed_today",
              "detail": "Positive; supports, but could not by itself prove or exclude, active tuberculosis",
              "guideline_ids": [
                "GL-CDC-4MO-2022",
                "GL-ATS-TB-2016"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "HIV test",
              "cadence": "At baseline",
              "status": "completed_today",
              "detail": "HIV-1/2 antigen and antibody negative",
              "guideline_ids": [
                "GL-CDC-4MO-2022",
                "GL-ATS-TB-2016"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Hepatitis B and C serology",
              "cadence": "At baseline",
              "status": "completed_today",
              "detail": "Hepatitis B surface antigen and core antibody negative, surface antibody positive (vaccinated); hepatitis C antibody negative",
              "guideline_ids": [
                "GL-CDC-4MO-2022",
                "GL-ATS-HEPATOTOX-2006"
              ]
            },
            {
              "domain": "imaging",
              "measure": "Chest X-ray",
              "cadence": "Baseline; at two months only if baseline cultures were negative; end of treatment optional",
              "status": "up_to_date",
              "detail": "Right upper lobe cavity on X-ray and CT at the first visit",
              "guideline_ids": [
                "GL-CDC-4MO-2022",
                "GL-ATS-TB-2016"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Doses observed and the completion clock (56 doses within 70 days, 63 within 84 days, 119 within five months)",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "Video-observed therapy set up with the health department; first dose observed in clinic today",
              "guideline_ids": [
                "GL-CDC-4MO-2022",
                "GL-ATS-TB-2016"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Drug interactions: rifapentine, and mineral products with moxifloxacin",
              "cadence": "With every new medicine or supplement",
              "status": "completed_today",
              "detail": "No other medicines; mineral products to be kept apart from moxifloxacin; orange urine and tears expected",
              "guideline_ids": [
                "GL-CDC-4MO-2022",
                "GL-ATS-TB-2016"
              ]
            },
            {
              "domain": "self_management",
              "measure": "Home airborne isolation and the release criteria",
              "cadence": "Until three negative smears, clinical improvement, and two weeks of treatment",
              "status": "completed_today",
              "detail": "Continues at home; lessons online",
              "guideline_ids": [
                "GL-CDC-CONTACT-2005",
                "GL-ATS-TB-2016"
              ]
            },
            {
              "domain": "referral",
              "measure": "Report to the health department",
              "cadence": "Same day as suspicion and on confirmation",
              "status": "completed_today",
              "detail": "Suspected case reported at the first visit; confirmation sent today",
              "guideline_ids": [
                "GL-CDC-CONTACT-2005",
                "GL-ATS-TB-2016"
              ]
            },
            {
              "domain": "referral",
              "measure": "Contact investigation (students, friends, close contacts)",
              "cadence": "Led by the health department from diagnosis",
              "status": "referred",
              "detail": "Health department listing his students and other close contacts; their results are not part of his record",
              "guideline_ids": [
                "GL-CDC-CONTACT-2005",
                "GL-ATS-TB-2016"
              ]
            },
            {
              "domain": "survey",
              "measure": "Depression screen (PHQ-9)",
              "cadence": "At diagnosis, at two months, and at the end of treatment",
              "status": "up_to_date",
              "detail": "7 at the first visit, item 9 scored 0",
              "guideline_ids": [
                "GL-USPSTF-DEP-2023"
              ]
            },
            {
              "domain": "self_management",
              "measure": "Nutrition: dietitian, intake, supplement drinks",
              "cadence": "Every visit until weight is restored",
              "status": "ordered",
              "detail": "First dietitian visit by video this week",
              "guideline_ids": [
                "GL-ASPEN-MALN-2012"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Sweat chloride and serum alpha-1 antitrypsin",
              "cadence": "Once, to address the alternatives",
              "status": "ordered",
              "detail": "Advised by infectious diseases; at the next visit, once he is out of isolation",
              "guideline_ids": [
                "GL-CFF-DX-2017",
                "GL-ATS-A1AT-2003"
              ]
            },
            {
              "domain": "referral",
              "measure": "Infectious diseases review",
              "cadence": "At diagnosis, at two months, and at the end of treatment",
              "status": "completed_today",
              "detail": "Seen today by Dr. Kowalczyk-Grant",
              "guideline_ids": [
                "GL-CDC-4MO-2022",
                "GL-ATS-TB-2016"
              ]
            }
          ],
          "follow_up": "Release smears in the third week, then review at about two and a half weeks with liver tests, the sweat chloride test, and the alpha-1 antitrypsin level. Call the same day for hepatitis symptoms or tendon pain",
          "guideline_ids": [
            "GL-CDC-4MO-2022",
            "GL-ATS-TB-2016",
            "GL-ATS-HEPATOTOX-2006",
            "GL-CDC-CONTACT-2005",
            "GL-CFF-DX-2017",
            "GL-ATS-A1AT-2003",
            "GL-ASPEN-MALN-2012",
            "GL-USPSTF-DEP-2023"
          ]
        }
      },
      {
        "id": "ENC-003",
        "display": "Two-and-a-half-week review: release from isolation, return to teaching, liver tests, and tests for cystic fibrosis and alpha-1 antitrypsin deficiency",
        "status": "finished",
        "date": "2026-04-07",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic modern EHR encounter.",
          "author": "The Human Record generator",
          "created": "2026-11-02T15:00:00-05:00"
        },
        "visit_type": "chronic_care",
        "type_coding": {
          "system": "http://snomed.info/sct",
          "code": "390906007",
          "display": "Follow-up encounter",
          "validation_status": "validated",
          "validated_on": "2026-11-04"
        },
        "documentation": {
          "chief_complaint": "Two-and-a-half-week review: release from isolation, return to teaching, liver tests, and tests for the alternatives",
          "hpi": {
            "narrative": "Mr. Chopin returns after nineteen days of treatment, all observed by video. The night sweats stopped in the second week, he has had no fever for ten days and no blood in his sputum for twelve, and his cough is now occasional. He had mild nausea in the first week, eased by taking the tablets in the middle of breakfast, and his urine and tears are orange as expected. He has no tendon pain, tingling, yellowing, dark urine, or rash. The three sputum smears collected in the third week were all negative, and the health department released him from isolation two days ago; he will start teaching in his studio again this week, beginning with eight lessons. The baseline cultures are growing Mycobacterium tuberculosis complex, and the molecular tests show no mutations for isoniazid or fluoroquinolone resistance. He has seen the dietitian twice and drinks two supplements a day in the afternoon and evening. His mood is better now that he can see his students. The sweat chloride test was done this morning.",
            "elements": [
              {
                "label": "Treatment",
                "value": "Nineteen of nineteen doses observed"
              },
              {
                "label": "Infection control",
                "value": "Three negative smears; released from isolation; teaching again this week"
              },
              {
                "label": "Microbiology",
                "value": "Cultures growing M. tuberculosis complex; no isoniazid or fluoroquinolone resistance mutations"
              },
              {
                "label": "Weight",
                "value": "49.6 kg, up 1.1 kg"
              }
            ]
          },
          "ros": [
            {
              "system": "Respiratory",
              "status": "positive",
              "finding": "Occasional cough; no blood for twelve days"
            },
            {
              "system": "Constitutional",
              "status": "negative",
              "finding": "No fever or night sweats; appetite returning"
            },
            {
              "system": "Gastrointestinal",
              "status": "negative",
              "finding": "Nausea gone; no abdominal pain or jaundice"
            },
            {
              "system": "Musculoskeletal",
              "status": "negative",
              "finding": "No tendon or joint pain"
            },
            {
              "system": "Neurological",
              "status": "negative",
              "finding": "No numbness or tingling"
            },
            {
              "system": "Psychiatric",
              "status": "negative",
              "finding": "Mood better; no thoughts of suicide or self-harm"
            }
          ],
          "exam": [
            {
              "system": "General",
              "finding": "Thin, brighter; weight 49.6 kg; temperature 37.0 °C"
            },
            {
              "system": "Eyes",
              "finding": "No icterus"
            },
            {
              "system": "Respiratory",
              "finding": "A few crackles at the right apex; no bronchial breathing"
            },
            {
              "system": "Musculoskeletal",
              "finding": "Tendons non-tender"
            },
            {
              "system": "Neurological",
              "finding": "Normal sensation in the fingers and feet"
            }
          ],
          "assessment_plan": [
            {
              "problem_id": "PRB-002",
              "display": "Pulmonary tuberculosis, intensive phase",
              "assessment": "Good early response with sputum smear conversion. Liver tests normal (ALT 34, AST 31, bilirubin 0.8). No isoniazid or fluoroquinolone resistance on molecular testing; phenotypic susceptibility pending",
              "plan": [
                "Continue the four drugs and pyridoxine daily by video with breakfast",
                "Monthly sputum culture: the samples from the third week are the first",
                "Back to teaching with the health department's agreement; no mask is needed now"
              ]
            },
            {
              "display": "Cystic fibrosis and alpha-1 antitrypsin deficiency",
              "assessment": "Sweat chloride 18 mmol/L, below 30, so cystic fibrosis is unlikely; alpha-1 antitrypsin 142 mg/dL, normal, so severe deficiency is excluded. With the CT showing no bronchiectasis or emphysema, neither explains his illness; tuberculosis does",
              "plan": [
                "No further testing for either"
              ]
            },
            {
              "problem_id": "PRB-003",
              "display": "Moderate protein-calorie malnutrition",
              "assessment": "Weight rising with treatment and supplements",
              "plan": [
                "Continue the dietitian's plan"
              ]
            }
          ],
          "monitoring": [
            {
              "domain": "examination",
              "measure": "Symptom review: cough, sputum, hemoptysis, fever, night sweats",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "Occasional cough; no fever, sweats, or blood",
              "guideline_ids": [
                "GL-CDC-4MO-2022",
                "GL-ATS-TB-2016"
              ]
            },
            {
              "domain": "examination",
              "measure": "Weight, with the pyrazinamide dose checked against the weight band",
              "cadence": "Monthly",
              "status": "completed_today",
              "detail": "49.6 kg; pyrazinamide band unchanged",
              "guideline_ids": [
                "GL-CDC-4MO-2022",
                "GL-ATS-TB-2016"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Adverse effects: hepatitis symptoms, tendon pain, numbness or tingling, rash, nausea, orange body fluids",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "Early nausea resolved; no tendon pain, tingling, rash, or jaundice",
              "guideline_ids": [
                "GL-CDC-4MO-2022",
                "GL-ATS-HEPATOTOX-2006"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Liver tests (ALT, AST, bilirubin)",
              "cadence": "Baseline; repeat for symptoms or risk factors (here at two to three weeks, for low weight and albumin)",
              "status": "completed_today",
              "detail": "ALT 34, AST 31 U/L, bilirubin 0.8 mg/dL, all normal",
              "observation_ids": [
                "OBS-ALT-V3",
                "OBS-AST-V3",
                "OBS-TBIL-V3"
              ],
              "guideline_ids": [
                "GL-CDC-4MO-2022",
                "GL-ATS-HEPATOTOX-2006"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Sputum acid-fast smear and culture",
              "cadence": "Baseline, then monthly until two consecutive cultures are negative",
              "status": "completed_today",
              "detail": "Three smears in the third week negative; baseline cultures growing M. tuberculosis complex; third-week cultures pending",
              "guideline_ids": [
                "GL-CDC-4MO-2022",
                "GL-ATS-TB-2016"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Rapid molecular testing for isoniazid and fluoroquinolone resistance",
              "cadence": "At baseline",
              "status": "completed_today",
              "detail": "No isoniazid (katG, inhA) or fluoroquinolone (gyrA, gyrB) resistance mutations",
              "guideline_ids": [
                "GL-CDC-4MO-2022",
                "GL-ATS-TB-2016"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Phenotypic susceptibility (rifampin, isoniazid, pyrazinamide, moxifloxacin)",
              "cadence": "At baseline",
              "status": "ordered",
              "detail": "Set up on the baseline isolate; pending",
              "guideline_ids": [
                "GL-CDC-4MO-2022",
                "GL-ATS-TB-2016"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Doses observed and the completion clock (56 doses within 70 days, 63 within 84 days, 119 within five months)",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "Nineteen of nineteen doses observed",
              "guideline_ids": [
                "GL-CDC-4MO-2022",
                "GL-ATS-TB-2016"
              ]
            },
            {
              "domain": "self_management",
              "measure": "Home airborne isolation and the release criteria",
              "cadence": "Until three negative smears, clinical improvement, and two weeks of treatment",
              "status": "completed_today",
              "detail": "Release criteria met; released by the health department two days ago",
              "guideline_ids": [
                "GL-CDC-CONTACT-2005",
                "GL-ATS-TB-2016"
              ]
            },
            {
              "domain": "referral",
              "measure": "Contact investigation (students, friends, close contacts)",
              "cadence": "Led by the health department from diagnosis",
              "status": "referred",
              "detail": "In progress with the health department; no results in his record",
              "guideline_ids": [
                "GL-CDC-CONTACT-2005",
                "GL-ATS-TB-2016"
              ]
            },
            {
              "domain": "self_management",
              "measure": "Nutrition: dietitian, intake, supplement drinks",
              "cadence": "Every visit until weight is restored",
              "status": "completed_today",
              "detail": "Two dietitian visits; two supplement drinks a day, apart from the dose",
              "guideline_ids": [
                "GL-ASPEN-MALN-2012"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Sweat chloride and serum alpha-1 antitrypsin",
              "cadence": "Once, to address the alternatives",
              "status": "completed_today",
              "detail": "Sweat chloride 18 mmol/L; alpha-1 antitrypsin 142 mg/dL; both normal",
              "observation_ids": [
                "OBS-SWCL-V3",
                "OBS-A1AT-V3"
              ],
              "guideline_ids": [
                "GL-CFF-DX-2017",
                "GL-ATS-A1AT-2003"
              ]
            },
            {
              "domain": "survey",
              "measure": "Depression screen (PHQ-9)",
              "cadence": "At diagnosis, at two months, and at the end of treatment",
              "status": "not_indicated",
              "detail": "Next at two months; mood better today",
              "guideline_ids": [
                "GL-USPSTF-DEP-2023"
              ]
            }
          ],
          "follow_up": "End-of-intensive-phase review in about five weeks, with the two-month sputum culture, liver tests, a blood count, and the PHQ-9",
          "guideline_ids": [
            "GL-CDC-4MO-2022",
            "GL-ATS-TB-2016",
            "GL-ATS-HEPATOTOX-2006",
            "GL-CDC-CONTACT-2005",
            "GL-CFF-DX-2017",
            "GL-ATS-A1AT-2003",
            "GL-ASPEN-MALN-2012"
          ]
        }
      },
      {
        "id": "ENC-004",
        "display": "End of the eight-week intensive phase: susceptibility results, the two-month sputum culture, and the start of the continuation phase",
        "status": "finished",
        "date": "2026-05-15",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic modern EHR encounter.",
          "author": "The Human Record generator",
          "created": "2026-11-02T15:00:00-05:00"
        },
        "visit_type": "chronic_care",
        "type_coding": {
          "system": "http://snomed.info/sct",
          "code": "390906007",
          "display": "Follow-up encounter",
          "validation_status": "validated",
          "validated_on": "2026-11-04"
        },
        "documentation": {
          "chief_complaint": "End of the eight-week intensive phase",
          "hpi": {
            "narrative": "Mr. Chopin completed the 56 doses of the intensive phase yesterday, all observed by video within eight weeks, and pyrazinamide has stopped; from today he takes rifapentine, moxifloxacin, isoniazid, and pyridoxine for nine more weeks. The isolate is susceptible to rifampin, isoniazid, pyrazinamide, and moxifloxacin. The cultures from the third week show no growth at six weeks. His cough has gone except for a little phlegm on waking, and he has gained 3.5 kg since diagnosis. He has no tendon pain, tingling, yellowing, or rash. He is teaching twelve students a week and has told them about his illness; none has left. The health department tells him the investigation of his contacts is going well, without giving him details.",
            "elements": [
              {
                "label": "Treatment",
                "value": "56 of 56 intensive-phase doses observed; continuation phase from today"
              },
              {
                "label": "Susceptibility",
                "value": "Susceptible to rifampin, isoniazid, pyrazinamide, and moxifloxacin"
              },
              {
                "label": "Cultures",
                "value": "Third-week cultures negative at six weeks"
              },
              {
                "label": "Weight",
                "value": "52.0 kg, up 3.5 kg"
              }
            ]
          },
          "ros": [
            {
              "system": "Respiratory",
              "status": "positive",
              "finding": "A little phlegm on waking; no cough during the day; no blood"
            },
            {
              "system": "Constitutional",
              "status": "negative",
              "finding": "No fever or night sweats; appetite good"
            },
            {
              "system": "Musculoskeletal",
              "status": "negative",
              "finding": "No tendon pain"
            },
            {
              "system": "Neurological",
              "status": "negative",
              "finding": "No numbness or tingling"
            },
            {
              "system": "Psychiatric",
              "status": "negative",
              "finding": "Mood good; PHQ-9 4; no thoughts of suicide or self-harm"
            }
          ],
          "exam": [
            {
              "system": "General",
              "finding": "Well; weight 52.0 kg"
            },
            {
              "system": "Eyes",
              "finding": "No icterus"
            },
            {
              "system": "Respiratory",
              "finding": "Clear apart from a few fine crackles at the right apex"
            },
            {
              "system": "Musculoskeletal",
              "finding": "Tendons non-tender"
            },
            {
              "system": "Neurological",
              "finding": "Normal sensation in the fingers and feet"
            }
          ],
          "assessment_plan": [
            {
              "problem_id": "PRB-002",
              "display": "Drug-susceptible pulmonary tuberculosis, continuation phase",
              "assessment": "Intensive phase completed on time with a full clinical response. Liver tests normal (ALT 29, AST 27, bilirubin 0.6). Hemoglobin 13.0, up from 12.1. Dr. Kowalczyk-Grant reviewed the results by message and agrees with continuing",
              "plan": [
                "Rifapentine 1200 mg, moxifloxacin 400 mg, isoniazid 300 mg, and pyridoxine daily by video for 63 doses",
                "Two-month sputum smear and culture today, from the morning sample"
              ]
            },
            {
              "problem_id": "PRB-003",
              "display": "Moderate protein-calorie malnutrition",
              "assessment": "Improving: BMI 18.0",
              "plan": [
                "Continue the supplements until his weight reaches 55 kg"
              ]
            }
          ],
          "monitoring": [
            {
              "domain": "examination",
              "measure": "Symptom review: cough, sputum, hemoptysis, fever, night sweats",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "Morning phlegm only",
              "guideline_ids": [
                "GL-CDC-4MO-2022",
                "GL-ATS-TB-2016"
              ]
            },
            {
              "domain": "examination",
              "measure": "Weight, with the pyrazinamide dose checked against the weight band",
              "cadence": "Monthly",
              "status": "completed_today",
              "detail": "52.0 kg; pyrazinamide finished within its band",
              "guideline_ids": [
                "GL-CDC-4MO-2022",
                "GL-ATS-TB-2016"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Adverse effects: hepatitis symptoms, tendon pain, numbness or tingling, rash, nausea, orange body fluids",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "None",
              "guideline_ids": [
                "GL-CDC-4MO-2022",
                "GL-ATS-HEPATOTOX-2006"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Liver tests (ALT, AST, bilirubin)",
              "cadence": "Baseline; repeat for symptoms or risk factors (here at two to three weeks, for low weight and albumin)",
              "status": "completed_today",
              "detail": "ALT 29, AST 27 U/L, bilirubin 0.6 mg/dL, all normal",
              "observation_ids": [
                "OBS-ALT-V4",
                "OBS-AST-V4",
                "OBS-TBIL-V4"
              ],
              "guideline_ids": [
                "GL-CDC-4MO-2022",
                "GL-ATS-HEPATOTOX-2006"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Hemoglobin",
              "cadence": "When low at baseline",
              "status": "completed_today",
              "detail": "13.0 g/dL, up from 12.1; anemia of inflammation resolving",
              "observation_ids": [
                "OBS-HGB-V4"
              ],
              "guideline_ids": [
                "GL-CDC-4MO-2022",
                "GL-ATS-TB-2016"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Phenotypic susceptibility (rifampin, isoniazid, pyrazinamide, moxifloxacin)",
              "cadence": "At baseline",
              "status": "completed_today",
              "detail": "Susceptible to rifampin, isoniazid, pyrazinamide, and moxifloxacin",
              "guideline_ids": [
                "GL-CDC-4MO-2022",
                "GL-ATS-TB-2016"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Sputum acid-fast smear and culture",
              "cadence": "Baseline, then monthly until two consecutive cultures are negative",
              "status": "completed_today",
              "detail": "Third-week cultures: no growth at six weeks (first negative culture)",
              "guideline_ids": [
                "GL-CDC-4MO-2022",
                "GL-ATS-TB-2016"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Two-month sputum culture",
              "cadence": "At the end of the intensive phase; a positive result needs evaluation and repeat susceptibility testing",
              "status": "completed_today",
              "detail": "Smear negative today; culture sent",
              "guideline_ids": [
                "GL-CDC-4MO-2022",
                "GL-ATS-TB-2016"
              ]
            },
            {
              "domain": "imaging",
              "measure": "Chest X-ray",
              "cadence": "Baseline; at two months only if baseline cultures were negative; end of treatment optional",
              "status": "not_indicated",
              "detail": "Not needed at two months, because the baseline cultures were positive",
              "guideline_ids": [
                "GL-CDC-4MO-2022",
                "GL-ATS-TB-2016"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Doses observed and the completion clock (56 doses within 70 days, 63 within 84 days, 119 within five months)",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "56 doses in 56 days, within the 70-day limit",
              "guideline_ids": [
                "GL-CDC-4MO-2022",
                "GL-ATS-TB-2016"
              ]
            },
            {
              "domain": "referral",
              "measure": "Contact investigation (students, friends, close contacts)",
              "cadence": "Led by the health department from diagnosis",
              "status": "referred",
              "detail": "Continuing with the health department; no results in his record",
              "guideline_ids": [
                "GL-CDC-CONTACT-2005",
                "GL-ATS-TB-2016"
              ]
            },
            {
              "domain": "survey",
              "measure": "Depression screen (PHQ-9)",
              "cadence": "At diagnosis, at two months, and at the end of treatment",
              "status": "completed_today",
              "detail": "4, item 9 scored 0",
              "observation_ids": [
                "OBS-PHQ9-V4"
              ],
              "guideline_ids": [
                "GL-USPSTF-DEP-2023"
              ]
            },
            {
              "domain": "self_management",
              "measure": "Nutrition: dietitian, intake, supplement drinks",
              "cadence": "Every visit until weight is restored",
              "status": "completed_today",
              "detail": "Supplements continue; eating well",
              "guideline_ids": [
                "GL-ASPEN-MALN-2012"
              ]
            },
            {
              "domain": "referral",
              "measure": "Infectious diseases review",
              "cadence": "At diagnosis, at two months, and at the end of treatment",
              "status": "completed_today",
              "detail": "Results reviewed by message today",
              "guideline_ids": [
                "GL-CDC-4MO-2022",
                "GL-ATS-TB-2016"
              ]
            }
          ],
          "follow_up": "End-of-treatment visit after the 119th dose. Call the same day for hepatitis symptoms, tendon pain, or a returning cough",
          "guideline_ids": [
            "GL-CDC-4MO-2022",
            "GL-ATS-TB-2016",
            "GL-ATS-HEPATOTOX-2006",
            "GL-CDC-CONTACT-2005",
            "GL-ASPEN-MALN-2012",
            "GL-USPSTF-DEP-2023"
          ]
        }
      },
      {
        "id": "ENC-005",
        "display": "End-of-treatment review after 119 doses",
        "status": "finished",
        "date": "2026-07-21",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic modern EHR encounter.",
          "author": "The Human Record generator",
          "created": "2026-11-02T15:00:00-05:00"
        },
        "visit_type": "chronic_care",
        "type_coding": {
          "system": "http://snomed.info/sct",
          "code": "390906007",
          "display": "Follow-up encounter",
          "validation_status": "validated",
          "validated_on": "2026-11-04"
        },
        "documentation": {
          "chief_complaint": "End-of-treatment review after 119 doses",
          "hpi": {
            "narrative": "Mr. Chopin returns five days after his 119th and last dose. He took every dose on his video calls, 56 in the intensive phase and 63 in the continuation phase, finishing in 17 weeks. The two-month culture grew nothing, so he has two consecutive negative cultures. The cold he had in June cleared within ten days. He has no cough, sputum, fever, night sweats, or blood, and he weighs 55.0 kg, 6.5 kg more than at diagnosis. He had no tendon pain or tingling at any point. Between the sick visit and today there was no clinic review; the health department nurse asked about symptoms and side effects on every video call. He is teaching his full schedule of fifteen students and has started practicing for a small recital.",
            "elements": [
              {
                "label": "Treatment",
                "value": "119 of 119 doses observed, completed in 17 weeks"
              },
              {
                "label": "Cultures",
                "value": "Third-week and two-month cultures negative"
              },
              {
                "label": "Weight",
                "value": "55.0 kg, up 6.5 kg since diagnosis"
              },
              {
                "label": "Work",
                "value": "Teaching fifteen students a week"
              }
            ]
          },
          "ros": [
            {
              "system": "Respiratory",
              "status": "negative",
              "finding": "No cough, sputum, hemoptysis, or breathlessness"
            },
            {
              "system": "Constitutional",
              "status": "negative",
              "finding": "No fever, night sweats, or weight loss"
            },
            {
              "system": "Musculoskeletal",
              "status": "negative",
              "finding": "No tendon pain"
            },
            {
              "system": "Neurological",
              "status": "negative",
              "finding": "No numbness or tingling"
            },
            {
              "system": "Psychiatric",
              "status": "negative",
              "finding": "Mood good; PHQ-9 3; no thoughts of suicide or self-harm"
            }
          ],
          "exam": [
            {
              "system": "General",
              "finding": "Well; weight 55.0 kg, BMI 19.0"
            },
            {
              "system": "Respiratory",
              "finding": "Clear, with no crackles"
            },
            {
              "system": "Abdomen",
              "finding": "Liver not enlarged"
            },
            {
              "system": "Musculoskeletal",
              "finding": "Tendons non-tender"
            },
            {
              "system": "Neurological",
              "finding": "Normal sensation and fine finger movements"
            }
          ],
          "assessment_plan": [
            {
              "problem_id": "PRB-002",
              "display": "Drug-susceptible pulmonary tuberculosis, treatment completed",
              "assessment": "Treatment completed under the 119-dose rule within five months, with culture conversion and a full clinical response. The chest X-ray today shows the cavity closed with a small area of right upper lobe scarring. Hemoglobin 14.1, albumin 4.0, and ALT 22 are normal. Dr. Kowalczyk-Grant reviewed the results by message and advises no routine follow-up",
              "plan": [
                "No further tuberculosis medicine",
                "Return the same day for a cough lasting more than two to three weeks, fever, night sweats, hemoptysis, or weight loss",
                "Today's X-ray is the baseline for any future comparison",
                "Health department notified that treatment is complete"
              ]
            },
            {
              "problem_id": "PRB-003",
              "display": "Moderate protein-calorie malnutrition, resolved",
              "assessment": "Weight 55.0 kg (BMI 19.0) and albumin 4.0: goal met",
              "plan": [
                "Stop the supplement drinks; keep three meals and two snacks a day"
              ]
            }
          ],
          "monitoring": [
            {
              "domain": "examination",
              "measure": "Symptom review: cough, sputum, hemoptysis, fever, night sweats",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "No symptoms",
              "guideline_ids": [
                "GL-CDC-4MO-2022",
                "GL-ATS-TB-2016"
              ]
            },
            {
              "domain": "examination",
              "measure": "Weight, with the pyrazinamide dose checked against the weight band",
              "cadence": "Monthly",
              "status": "completed_today",
              "detail": "55.0 kg",
              "guideline_ids": [
                "GL-CDC-4MO-2022",
                "GL-ATS-TB-2016"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Adverse effects: hepatitis symptoms, tendon pain, numbness or tingling, rash, nausea, orange body fluids",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "None at any visit or video call",
              "guideline_ids": [
                "GL-CDC-4MO-2022",
                "GL-ATS-HEPATOTOX-2006"
              ]
            },
            {
              "domain": "examination",
              "measure": "Clinical review (adherence, symptoms, adverse effects, weight)",
              "cadence": "At least monthly during treatment",
              "status": "deferred",
              "detail": "No clinic review between the sick visit in early June and today, about six weeks, because the schedule went from the end of the intensive phase to the end of treatment. The nurse reviewed symptoms and side effects on every video call, and today's examination, weight, and tests are normal, so no harm is evident. Corrective action: monthly clinic reviews booked at the start of treatment for every patient on the four-month regimen",
              "guideline_ids": [
                "GL-CDC-4MO-2022",
                "GL-ATS-TB-2016"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Liver tests (ALT, AST, bilirubin)",
              "cadence": "Baseline; repeat for symptoms or risk factors (here at two to three weeks, for low weight and albumin)",
              "status": "completed_today",
              "detail": "ALT 22 U/L at the end of treatment",
              "observation_ids": [
                "OBS-ALT-V5"
              ],
              "guideline_ids": [
                "GL-CDC-4MO-2022",
                "GL-ATS-HEPATOTOX-2006"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Hemoglobin and albumin",
              "cadence": "At the end of treatment when low at baseline",
              "status": "completed_today",
              "detail": "Hemoglobin 14.1 g/dL; albumin 4.0 g/dL",
              "observation_ids": [
                "OBS-HGB-V5",
                "OBS-ALB-V5"
              ],
              "guideline_ids": [
                "GL-ATS-TB-2016",
                "GL-ASPEN-MALN-2012"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Sputum acid-fast smear and culture",
              "cadence": "Baseline, then monthly until two consecutive cultures are negative",
              "status": "completed_today",
              "detail": "Two consecutive negative cultures (third week and two months); no further sputum needed",
              "guideline_ids": [
                "GL-CDC-4MO-2022",
                "GL-ATS-TB-2016"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Two-month sputum culture",
              "cadence": "At the end of the intensive phase; a positive result needs evaluation and repeat susceptibility testing",
              "status": "completed_today",
              "detail": "No growth",
              "guideline_ids": [
                "GL-CDC-4MO-2022",
                "GL-ATS-TB-2016"
              ]
            },
            {
              "domain": "imaging",
              "measure": "Chest X-ray",
              "cadence": "Baseline; at two months only if baseline cultures were negative; end of treatment optional",
              "status": "completed_today",
              "detail": "Cavity closed; small area of right upper lobe scarring",
              "guideline_ids": [
                "GL-CDC-4MO-2022",
                "GL-ATS-TB-2016"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Doses observed and the completion clock (56 doses within 70 days, 63 within 84 days, 119 within five months)",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "119 doses in 17 weeks, within five months",
              "guideline_ids": [
                "GL-CDC-4MO-2022",
                "GL-ATS-TB-2016"
              ]
            },
            {
              "domain": "referral",
              "measure": "Notification of treatment completion",
              "cadence": "At the end of treatment",
              "status": "completed_today",
              "detail": "Sent to the health department today",
              "guideline_ids": [
                "GL-CDC-CONTACT-2005",
                "GL-ATS-TB-2016"
              ]
            },
            {
              "domain": "survey",
              "measure": "Depression screen (PHQ-9)",
              "cadence": "At diagnosis, at two months, and at the end of treatment",
              "status": "completed_today",
              "detail": "3, item 9 scored 0",
              "observation_ids": [
                "OBS-PHQ9-V5"
              ],
              "guideline_ids": [
                "GL-USPSTF-DEP-2023"
              ]
            },
            {
              "domain": "self_management",
              "measure": "Nutrition: dietitian, intake, supplement drinks",
              "cadence": "Every visit until weight is restored",
              "status": "completed_today",
              "detail": "Weight goal met; supplements stopped",
              "guideline_ids": [
                "GL-ASPEN-MALN-2012"
              ]
            },
            {
              "domain": "referral",
              "measure": "Infectious diseases review",
              "cadence": "At diagnosis, at two months, and at the end of treatment",
              "status": "completed_today",
              "detail": "Results reviewed by message; no routine follow-up",
              "guideline_ids": [
                "GL-CDC-4MO-2022",
                "GL-ATS-TB-2016"
              ]
            }
          ],
          "follow_up": "Adult preventive visit in about two months. Same-day visit for symptoms of relapse",
          "guideline_ids": [
            "GL-CDC-4MO-2022",
            "GL-ATS-TB-2016",
            "GL-ATS-HEPATOTOX-2006",
            "GL-CDC-CONTACT-2005",
            "GL-ASPEN-MALN-2012",
            "GL-USPSTF-DEP-2023"
          ]
        }
      },
      {
        "id": "ENC-006",
        "display": "Same-day sick visit for a cold with cough during tuberculosis treatment",
        "status": "finished",
        "date": "2026-06-09",
        "visit_type": "sick",
        "type_coding": {
          "system": "http://snomed.info/sct",
          "code": "185345009",
          "display": "Encounter for symptom",
          "validation_status": "validated",
          "validated_on": "2026-11-04"
        },
        "documentation": {
          "chief_complaint": "Sore throat, runny nose, and cough for three days during tuberculosis treatment",
          "billing_note": "Problem-oriented office visit, established patient",
          "hpi": {
            "narrative": "Mr. Chopin is a 28-year-old pianist in the fourth week of the continuation phase of rifapentine, moxifloxacin, and isoniazid for cavitary pulmonary tuberculosis, given by video-observed therapy. Three days ago he developed a scratchy throat and a runny, blocked nose, then a mild dry cough; two of his students had colds last week. His temperature at home has been up to 37.7 °C. He is frightened that the tuberculosis is coming back, because the cough is the first he has had in a month. He has no blood in his sputum, no night sweats, and no weight loss; he has gained 1.6 kg since the end of the intensive phase. He has taken every dose on his video calls. He has not taken anything for the cold yet and asked whether zinc lozenges or an antibiotic would help. He has no tendon pain, tingling, rash, yellowing, or dark urine.",
            "elements": [
              {
                "label": "Onset",
                "value": "Three days ago"
              },
              {
                "label": "Location",
                "value": "Throat and nose, with a mild cough"
              },
              {
                "label": "Duration",
                "value": "Three days"
              },
              {
                "label": "Character",
                "value": "Scratchy throat, runny and blocked nose, dry cough"
              },
              {
                "label": "Severity",
                "value": "Mild; teaching with difficulty"
              },
              {
                "label": "Timing",
                "value": "Week 12 of 17 of tuberculosis treatment"
              },
              {
                "label": "Context",
                "value": "Students with colds last week"
              },
              {
                "label": "Modifying factors",
                "value": "Nothing taken yet; no doses missed"
              },
              {
                "label": "Associated signs and symptoms",
                "value": "Temperature up to 37.7 °C; no hemoptysis, night sweats, or weight loss"
              }
            ]
          },
          "ros": [
            {
              "system": "Constitutional",
              "status": "positive",
              "finding": "Low-grade temperature; no night sweats or weight loss"
            },
            {
              "system": "Ears, nose, mouth, and throat",
              "status": "positive",
              "finding": "Sore throat, runny and blocked nose; no ear pain"
            },
            {
              "system": "Respiratory",
              "status": "positive",
              "finding": "Mild dry cough for two days; no blood, breathlessness, or chest pain"
            },
            {
              "system": "Gastrointestinal",
              "status": "negative",
              "finding": "No nausea, abdominal pain, or jaundice"
            },
            {
              "system": "Musculoskeletal",
              "status": "negative",
              "finding": "No tendon or joint pain"
            },
            {
              "system": "Neurological",
              "status": "negative",
              "finding": "No numbness or tingling in his fingers or feet"
            }
          ],
          "exam": [
            {
              "system": "General",
              "finding": "Tired but well; weight 53.6 kg; temperature 37.6 °C; masked in the waiting room"
            },
            {
              "system": "Ears, nose, and throat",
              "finding": "Nasal mucosa red and swollen with clear discharge; pharynx mildly red without exudate; ear drums normal"
            },
            {
              "system": "Neck",
              "finding": "Small, soft, tender anterior lymph nodes"
            },
            {
              "system": "Respiratory",
              "finding": "Clear, with no crackles or bronchial breathing over the right upper zone"
            },
            {
              "system": "Skin",
              "finding": "No rash or jaundice"
            }
          ],
          "assessment_plan": [
            {
              "problem_id": "PRB-004",
              "display": "Acute viral upper respiratory infection",
              "assessment": "A cold caught from his students: a short illness with a sore throat and runny nose before the cough, a normal chest examination, and continued weight gain. This is not tuberculosis treatment failure, which would bring back cough with sputum, night sweats, weight loss, or hemoptysis over weeks, and his April cultures were negative. Antibiotics would not help. Zinc lozenges and mineral-containing cold remedies bind moxifloxacin and lower its absorption, and an antibiotic such as azithromycin would add to the QT effect of moxifloxacin",
              "plan": [
                "Fluids, honey, rest, and saline nose spray; acetaminophen for throat pain or fever",
                "No zinc lozenges or mineral-containing remedies within four hours before or eight hours after his morning dose; no antibiotic",
                "Keep taking every dose on the video calls",
                "Wear a mask while coughing and move lessons online for a few days, as anyone with a cold would",
                "Return for a cough lasting beyond two to three weeks, blood in the sputum, night sweats, or weight loss, for sputum smear and culture"
              ]
            },
            {
              "problem_id": "PRB-002",
              "display": "Pulmonary tuberculosis, continuation phase",
              "assessment": "Responding well: symptoms of tuberculosis gone, weight rising, every dose observed. No tendon pain, tingling, or signs of liver injury",
              "plan": [
                "Continue rifapentine, moxifloxacin, isoniazid, and pyridoxine to the 119th dose"
              ]
            }
          ],
          "follow_up": "Message if the cold is not better in a week. End-of-treatment visit after the last dose in July",
          "guideline_ids": [
            "GL-ARTI-2016",
            "GL-CDC-4MO-2022",
            "GL-ATS-TB-2016"
          ]
        },
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0004",
            "CLM-0014",
            "CLM-0016"
          ],
          "synthetic_reason": "Synthetic unscheduled sick visit.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:00:00-05:00"
        }
      },
      {
        "id": "ENC-007",
        "display": "Adult preventive visit",
        "status": "finished",
        "date": "2026-09-15",
        "visit_type": "preventive_adult",
        "type_coding": {
          "system": "http://snomed.info/sct",
          "code": "86013001",
          "display": "Periodic reevaluation and management of healthy individual",
          "validation_status": "validated",
          "validated_on": "2026-11-04"
        },
        "documentation": {
          "chief_complaint": "Adult preventive visit; no new complaints",
          "billing_note": "CPT 99395 (periodic preventive medicine, established patient, age 18 to 39)",
          "hpi": {
            "narrative": "Mr. Chopin returns for his adult preventive visit eight weeks after completing tuberculosis treatment. He has had no cough, fever, night sweats, or weight loss since, and he has gained another 1.2 kg. He teaches his full schedule of about fifteen students a week and is preparing a small recital. He has a glass of wine with dinner a few times a week and has never smoked. His mood is good. He completed the health risk assessment before the visit.",
            "elements": [
              {
                "label": "Visit",
                "value": "Adult preventive visit, age 28"
              },
              {
                "label": "Active conditions",
                "value": "Pulmonary tuberculosis, treatment completed; malnutrition resolved"
              },
              {
                "label": "Medicines",
                "value": "None since tuberculosis treatment ended"
              },
              {
                "label": "Functional status",
                "value": "Independent; teaching full time"
              }
            ]
          },
          "health_risk_assessment": [
            {
              "domain": "Self-rated health",
              "finding": "Good, much better than in the spring"
            },
            {
              "domain": "Psychosocial",
              "finding": "Supported by friends from home and by his students; he told his students about the illness and none left"
            },
            {
              "domain": "Behavioral",
              "finding": "A glass of wine with dinner a few times a week (AUDIT-C 2); no tobacco or other drugs"
            },
            {
              "domain": "Nutrition",
              "finding": "Three meals and two snacks a day; no supplement drinks since August"
            },
            {
              "domain": "Physical activity",
              "finding": "Walks about 30 minutes most days"
            },
            {
              "domain": "Activities of daily living",
              "finding": "Independent in all"
            },
            {
              "domain": "Sleep",
              "finding": "About seven hours a night; no night sweats"
            },
            {
              "domain": "Safety",
              "finding": "No firearms; smoke detector working; wears a seat belt"
            },
            {
              "domain": "Hearing and vision",
              "finding": "No concerns"
            },
            {
              "domain": "Sexual health",
              "finding": "Discussed privately; no concerns"
            }
          ],
          "ros": [
            {
              "system": "Constitutional",
              "status": "negative",
              "finding": "Weight up; no fever or night sweats"
            },
            {
              "system": "Eyes",
              "status": "negative",
              "finding": "No change in vision"
            },
            {
              "system": "Ears, nose, mouth, and throat",
              "status": "negative",
              "finding": "No sore throat or hoarseness"
            },
            {
              "system": "Cardiovascular",
              "status": "negative",
              "finding": "No chest pain or palpitations"
            },
            {
              "system": "Respiratory",
              "status": "negative",
              "finding": "No cough, sputum, hemoptysis, or breathlessness"
            },
            {
              "system": "Gastrointestinal",
              "status": "negative",
              "finding": "No abdominal pain, greasy stools, or change in bowel habit"
            },
            {
              "system": "Genitourinary",
              "status": "negative",
              "finding": "No urinary symptoms"
            },
            {
              "system": "Musculoskeletal",
              "status": "negative",
              "finding": "No tendon or joint pain"
            },
            {
              "system": "Integumentary",
              "status": "negative",
              "finding": "No rash"
            },
            {
              "system": "Neurological",
              "status": "negative",
              "finding": "No numbness or tingling in his fingers"
            },
            {
              "system": "Psychiatric",
              "status": "negative",
              "finding": "Mood good; PHQ-2 score 0"
            }
          ],
          "exam": [
            {
              "system": "Constitutional",
              "finding": "Well; slim; BMI 19.4"
            },
            {
              "system": "Eyes",
              "finding": "Conjunctivae normal"
            },
            {
              "system": "Ears, nose, and throat",
              "finding": "Normal; no nasal polyps"
            },
            {
              "system": "Neck",
              "finding": "No lymph nodes"
            },
            {
              "system": "Cardiovascular",
              "finding": "Regular rhythm; no murmur"
            },
            {
              "system": "Respiratory",
              "finding": "Clear; no crackles"
            },
            {
              "system": "Abdomen",
              "finding": "Soft; liver not enlarged"
            },
            {
              "system": "Extremities",
              "finding": "No clubbing"
            },
            {
              "system": "Skin",
              "finding": "No rash or suspicious lesions"
            },
            {
              "system": "Neurological",
              "finding": "Normal sensation and fine finger movements"
            }
          ],
          "assessment_plan": [
            {
              "display": "Adult preventive visit completed",
              "assessment": "Health risk assessment reviewed and a written prevention plan given. PHQ-2 0. AUDIT-C 2, below the risk threshold for men",
              "plan": [
                "Next preventive visit in one year"
              ]
            },
            {
              "problem_id": "PRB-002",
              "display": "Pulmonary tuberculosis, treatment completed",
              "assessment": "No symptoms of relapse two months after completing treatment",
              "plan": [
                "No routine tests; a skin or blood test would stay positive and is not repeated",
                "Same-day visit for a cough lasting more than two to three weeks, fever, night sweats, hemoptysis, or weight loss"
              ]
            }
          ],
          "prevention_plan": [
            {
              "service": "Influenza vaccine, 2026-2027",
              "status": "completed_today",
              "detail": "Given today",
              "guideline_ids": [
                "GL-CDC-ADULT-2026"
              ]
            },
            {
              "service": "COVID-19 vaccine, 2026-2027",
              "status": "due",
              "detail": "Recommended; he will get it at his pharmacy",
              "guideline_ids": [
                "GL-CDC-ADULT-2026"
              ]
            },
            {
              "service": "Tetanus, diphtheria, and pertussis booster",
              "status": "up_to_date",
              "detail": "Tdap about three years ago",
              "guideline_ids": [
                "GL-CDC-ADULT-2026"
              ]
            },
            {
              "service": "Hepatitis B vaccine",
              "status": "up_to_date",
              "detail": "Immune by surface antibody at the tuberculosis diagnosis",
              "guideline_ids": [
                "GL-CDC-ADULT-2026"
              ]
            },
            {
              "service": "HPV vaccine",
              "status": "up_to_date",
              "detail": "Series completed in adolescence by his report",
              "guideline_ids": [
                "GL-CDC-ADULT-2026"
              ]
            },
            {
              "service": "HIV screening",
              "status": "up_to_date",
              "detail": "Negative at the tuberculosis diagnosis",
              "guideline_ids": [
                "GL-USPSTF-AB"
              ]
            },
            {
              "service": "Hepatitis C screening",
              "status": "up_to_date",
              "detail": "Antibody negative at the tuberculosis diagnosis",
              "guideline_ids": [
                "GL-USPSTF-AB"
              ]
            },
            {
              "service": "Tuberculosis testing",
              "status": "not_indicated",
              "detail": "Treated for active tuberculosis; the blood test stays positive; symptom review instead"
            },
            {
              "service": "Depression screening",
              "status": "completed_today",
              "detail": "PHQ-2 score 0",
              "guideline_ids": [
                "GL-USPSTF-DEP-2023"
              ]
            },
            {
              "service": "Unhealthy alcohol use screening",
              "status": "completed_today",
              "detail": "AUDIT-C 2, below the risk threshold",
              "guideline_ids": [
                "GL-USPSTF-AB"
              ]
            },
            {
              "service": "Tobacco use",
              "status": "completed_today",
              "detail": "Never used"
            },
            {
              "service": "Blood pressure screening",
              "status": "completed_today",
              "detail": "112/70 mmHg",
              "guideline_ids": [
                "GL-USPSTF-AB"
              ]
            },
            {
              "service": "Diabetes screening",
              "status": "not_indicated",
              "detail": "Recommended from 35 for adults with overweight or obesity; BMI 19.4",
              "guideline_ids": [
                "GL-USPSTF-AB"
              ]
            },
            {
              "service": "Sexual health and STI screening",
              "status": "completed_today",
              "detail": "Discussed privately; no screening indicated by his history",
              "guideline_ids": [
                "GL-USPSTF-AB"
              ]
            }
          ],
          "advance_care_planning": "Brief voluntary discussion, offered because of this year's serious illness. He wants to think about whom to name as his health care agent and was given the state's health care directive form. No treatment preferences are recorded.",
          "follow_up": "Next preventive visit in one year; same-day visit for symptoms of relapse",
          "guideline_ids": [
            "GL-PREV-2026",
            "GL-USPSTF-AB",
            "GL-CDC-ADULT-2026",
            "GL-USPSTF-DEP-2023"
          ]
        },
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic adult preventive visit.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:00:00-05:00"
        }
      }
    ],
    "vital_sign_sets": [
      {
        "id": "VSET-001",
        "date": "2026-03-17",
        "measurements": [
          {
            "code": "8302-2",
            "display": "Body height",
            "value": 170,
            "unit": "cm"
          },
          {
            "code": "29463-7",
            "display": "Body weight",
            "value": 48.5,
            "unit": "kg"
          },
          {
            "code": "39156-5",
            "display": "Body mass index (BMI) [Ratio]",
            "value": 16.8,
            "unit": "kg/m2"
          },
          {
            "code": "8480-6",
            "display": "Systolic blood pressure",
            "value": 104,
            "unit": "mm[Hg]"
          },
          {
            "code": "8462-4",
            "display": "Diastolic blood pressure",
            "value": 66,
            "unit": "mm[Hg]"
          },
          {
            "code": "8867-4",
            "display": "Heart rate",
            "value": 102,
            "unit": "/min"
          },
          {
            "code": "9279-1",
            "display": "Respiratory rate",
            "value": 20,
            "unit": "/min"
          },
          {
            "code": "8310-5",
            "display": "Body temperature",
            "value": 37.9,
            "unit": "Cel"
          },
          {
            "code": "59408-5",
            "display": "Oxygen saturation in Arterial blood by Pulse oximetry",
            "value": 95,
            "unit": "%"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0004",
            "CLM-0020"
          ],
          "synthetic_reason": "Synthetic seated vital signs with fever and a fast pulse from active tuberculosis.",
          "author": "The Human Record generator",
          "created": "2026-11-02T15:00:00-05:00"
        }
      },
      {
        "id": "VSET-002",
        "date": "2026-03-20",
        "measurements": [
          {
            "code": "8302-2",
            "display": "Body height",
            "value": 170,
            "unit": "cm"
          },
          {
            "code": "29463-7",
            "display": "Body weight",
            "value": 48.4,
            "unit": "kg"
          },
          {
            "code": "39156-5",
            "display": "Body mass index (BMI) [Ratio]",
            "value": 16.7,
            "unit": "kg/m2"
          },
          {
            "code": "8480-6",
            "display": "Systolic blood pressure",
            "value": 102,
            "unit": "mm[Hg]"
          },
          {
            "code": "8462-4",
            "display": "Diastolic blood pressure",
            "value": 64,
            "unit": "mm[Hg]"
          },
          {
            "code": "8867-4",
            "display": "Heart rate",
            "value": 98,
            "unit": "/min"
          },
          {
            "code": "9279-1",
            "display": "Respiratory rate",
            "value": 18,
            "unit": "/min"
          },
          {
            "code": "8310-5",
            "display": "Body temperature",
            "value": 37.6,
            "unit": "Cel"
          },
          {
            "code": "59408-5",
            "display": "Oxygen saturation in Arterial blood by Pulse oximetry",
            "value": 95,
            "unit": "%"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0004",
            "CLM-0014",
            "CLM-0016"
          ],
          "synthetic_reason": "Synthetic seated vital signs, taken in an airborne infection isolation room.",
          "author": "The Human Record generator",
          "created": "2026-11-02T15:00:00-05:00"
        }
      },
      {
        "id": "VSET-003",
        "date": "2026-04-07",
        "measurements": [
          {
            "code": "8302-2",
            "display": "Body height",
            "value": 170,
            "unit": "cm"
          },
          {
            "code": "29463-7",
            "display": "Body weight",
            "value": 49.6,
            "unit": "kg"
          },
          {
            "code": "39156-5",
            "display": "Body mass index (BMI) [Ratio]",
            "value": 17.2,
            "unit": "kg/m2"
          },
          {
            "code": "8480-6",
            "display": "Systolic blood pressure",
            "value": 106,
            "unit": "mm[Hg]"
          },
          {
            "code": "8462-4",
            "display": "Diastolic blood pressure",
            "value": 66,
            "unit": "mm[Hg]"
          },
          {
            "code": "8867-4",
            "display": "Heart rate",
            "value": 86,
            "unit": "/min"
          },
          {
            "code": "9279-1",
            "display": "Respiratory rate",
            "value": 16,
            "unit": "/min"
          },
          {
            "code": "8310-5",
            "display": "Body temperature",
            "value": 37.0,
            "unit": "Cel"
          },
          {
            "code": "59408-5",
            "display": "Oxygen saturation in Arterial blood by Pulse oximetry",
            "value": 97,
            "unit": "%"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic seated vital signs.",
          "author": "The Human Record generator",
          "created": "2026-11-02T15:00:00-05:00"
        }
      },
      {
        "id": "VSET-004",
        "date": "2026-05-15",
        "measurements": [
          {
            "code": "8302-2",
            "display": "Body height",
            "value": 170,
            "unit": "cm"
          },
          {
            "code": "29463-7",
            "display": "Body weight",
            "value": 52.0,
            "unit": "kg"
          },
          {
            "code": "39156-5",
            "display": "Body mass index (BMI) [Ratio]",
            "value": 18.0,
            "unit": "kg/m2"
          },
          {
            "code": "8480-6",
            "display": "Systolic blood pressure",
            "value": 108,
            "unit": "mm[Hg]"
          },
          {
            "code": "8462-4",
            "display": "Diastolic blood pressure",
            "value": 68,
            "unit": "mm[Hg]"
          },
          {
            "code": "8867-4",
            "display": "Heart rate",
            "value": 78,
            "unit": "/min"
          },
          {
            "code": "9279-1",
            "display": "Respiratory rate",
            "value": 16,
            "unit": "/min"
          },
          {
            "code": "8310-5",
            "display": "Body temperature",
            "value": 36.8,
            "unit": "Cel"
          },
          {
            "code": "59408-5",
            "display": "Oxygen saturation in Arterial blood by Pulse oximetry",
            "value": 98,
            "unit": "%"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic seated vital signs.",
          "author": "The Human Record generator",
          "created": "2026-11-02T15:00:00-05:00"
        }
      },
      {
        "id": "VSET-005",
        "date": "2026-07-21",
        "measurements": [
          {
            "code": "8302-2",
            "display": "Body height",
            "value": 170,
            "unit": "cm"
          },
          {
            "code": "29463-7",
            "display": "Body weight",
            "value": 55.0,
            "unit": "kg"
          },
          {
            "code": "39156-5",
            "display": "Body mass index (BMI) [Ratio]",
            "value": 19.0,
            "unit": "kg/m2"
          },
          {
            "code": "8480-6",
            "display": "Systolic blood pressure",
            "value": 110,
            "unit": "mm[Hg]"
          },
          {
            "code": "8462-4",
            "display": "Diastolic blood pressure",
            "value": 70,
            "unit": "mm[Hg]"
          },
          {
            "code": "8867-4",
            "display": "Heart rate",
            "value": 72,
            "unit": "/min"
          },
          {
            "code": "9279-1",
            "display": "Respiratory rate",
            "value": 14,
            "unit": "/min"
          },
          {
            "code": "8310-5",
            "display": "Body temperature",
            "value": 36.6,
            "unit": "Cel"
          },
          {
            "code": "59408-5",
            "display": "Oxygen saturation in Arterial blood by Pulse oximetry",
            "value": 98,
            "unit": "%"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic seated vital signs.",
          "author": "The Human Record generator",
          "created": "2026-11-02T15:00:00-05:00"
        }
      },
      {
        "id": "VSET-006",
        "date": "2026-06-09",
        "measurements": [
          {
            "code": "8302-2",
            "display": "Body height",
            "value": 170,
            "unit": "cm"
          },
          {
            "code": "29463-7",
            "display": "Body weight",
            "value": 53.6,
            "unit": "kg"
          },
          {
            "code": "39156-5",
            "display": "Body mass index (BMI) [Ratio]",
            "value": 18.5,
            "unit": "kg/m2"
          },
          {
            "code": "8480-6",
            "display": "Systolic blood pressure",
            "value": 108,
            "unit": "mm[Hg]"
          },
          {
            "code": "8462-4",
            "display": "Diastolic blood pressure",
            "value": 68,
            "unit": "mm[Hg]"
          },
          {
            "code": "8867-4",
            "display": "Heart rate",
            "value": 88,
            "unit": "/min"
          },
          {
            "code": "9279-1",
            "display": "Respiratory rate",
            "value": 16,
            "unit": "/min"
          },
          {
            "code": "8310-5",
            "display": "Body temperature",
            "value": 37.6,
            "unit": "Cel"
          },
          {
            "code": "59408-5",
            "display": "Oxygen saturation in Arterial blood by Pulse oximetry",
            "value": 97,
            "unit": "%"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic seated vital signs during a cold.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:00:00-05:00"
        }
      },
      {
        "id": "VSET-007",
        "date": "2026-09-15",
        "measurements": [
          {
            "code": "8302-2",
            "display": "Body height",
            "value": 170,
            "unit": "cm"
          },
          {
            "code": "29463-7",
            "display": "Body weight",
            "value": 56.2,
            "unit": "kg"
          },
          {
            "code": "39156-5",
            "display": "Body mass index (BMI) [Ratio]",
            "value": 19.4,
            "unit": "kg/m2"
          },
          {
            "code": "8480-6",
            "display": "Systolic blood pressure",
            "value": 112,
            "unit": "mm[Hg]"
          },
          {
            "code": "8462-4",
            "display": "Diastolic blood pressure",
            "value": 70,
            "unit": "mm[Hg]"
          },
          {
            "code": "8867-4",
            "display": "Heart rate",
            "value": 70,
            "unit": "/min"
          },
          {
            "code": "9279-1",
            "display": "Respiratory rate",
            "value": 14,
            "unit": "/min"
          },
          {
            "code": "8310-5",
            "display": "Body temperature",
            "value": 36.6,
            "unit": "Cel"
          },
          {
            "code": "59408-5",
            "display": "Oxygen saturation in Arterial blood by Pulse oximetry",
            "value": 98,
            "unit": "%"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic seated vital signs at the preventive visit.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:00:00-05:00"
        }
      }
    ],
    "social_history": [
      {
        "id": "SOC-001",
        "display": "Concert pianist and composer who earns most of his living teaching piano in the studio of his apartment; performs a few times a year and prefers small gatherings to large halls",
        "status": "current",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0006"
          ],
          "synthetic_reason": "Synthetic modern occupation anchored to his documented teaching and performing.",
          "author": "The Human Record generator",
          "created": "2026-11-02T15:00:00-05:00"
        }
      },
      {
        "id": "SOC-002",
        "display": "Born in Poland to a French father and a Polish mother; left home at 20 and has not been back; sources of support he names: a close circle of friends from home, his students, and his music",
        "status": "current",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0002",
            "CLM-0005"
          ],
          "synthetic_reason": "Synthetic modern background and strengths; no decision, statement, or health fact is attributed to any relative.",
          "author": "The Human Record generator",
          "created": "2026-11-02T15:00:00-05:00"
        }
      },
      {
        "id": "SOC-003",
        "display": "Lives alone; teaches about fifteen students a week, teenagers and adults, in his apartment; no children under five and no one with a weakened immune system among his close contacts that he knows of",
        "status": "current",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic household and contacts, recorded for isolation and the contact investigation; it names no real person.",
          "author": "The Human Record generator",
          "created": "2026-11-02T15:00:00-05:00"
        }
      },
      {
        "id": "SOC-004",
        "display": "Alcohol: a glass of wine with dinner a few times a week (AUDIT-C 2); never smoked; no drug use; no incarceration, homelessness, or work in health care",
        "status": "current",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic risk-factor history for tuberculosis, liver risk, and HIV testing.",
          "author": "The Human Record generator",
          "created": "2026-11-02T15:00:00-05:00"
        }
      }
    ],
    "functional_status": [
      {
        "id": "FUNC-001",
        "display": "Independent; has cut his teaching from about fifteen to eight lessons a week over the past month because of tiredness, cough, and night sweats",
        "status": "current",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0004",
            "CLM-0020"
          ],
          "synthetic_reason": "Synthetic functional status.",
          "author": "The Human Record generator",
          "created": "2026-11-02T15:00:00-05:00"
        }
      }
    ],
    "mental_status": [
      {
        "id": "MSE-001",
        "display": "Quiet, courteous, and precise; organized thought; thin and tired",
        "status": "current",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic mental-status finding.",
          "author": "The Human Record generator",
          "created": "2026-11-02T15:00:00-05:00"
        }
      },
      {
        "id": "MSE-002",
        "display": "Mood low and anxious about the illness and his students; homesick; PHQ-9 7, with item 9 scored 0; no thoughts of suicide or self-harm",
        "status": "current",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0010"
          ],
          "synthetic_reason": "Synthetic mental-status finding.",
          "author": "The Human Record generator",
          "created": "2026-11-02T15:00:00-05:00"
        }
      }
    ],
    "consultation": {
      "referral": {
        "question": "Suspected cavitary pulmonary tuberculosis in a 28-year-old pianist and piano teacher with three months of cough, blood-streaked sputum, night sweats, and weight loss, and a lifelong history of chest illness. Please confirm the diagnosis when the sputum results return, advise on the regimen, monitoring, and his return to teaching, and tell us whether cystic fibrosis or alpha-1 antitrypsin deficiency needs to be excluded",
        "urgency": "Urgent, on the day the sputum results return (expected within three days)",
        "pertinent_history": "Cough for three months, blood streaks for two weeks, evening fevers, night sweats, and weight loss of about 6 kg to 48.5 kg (BMI 16.8). Temperature 37.9 °C, pulse 102, oxygen saturation 95 percent. Recurrent coughs and fevers since his teens. Born in Poland; lives alone and teaches about fifteen students a week, teenagers and adults, in his apartment. Chest X-ray and CT: a 2.5 cm thick-walled right upper lobe cavity with tree-in-bud nodules in both upper lobes; no bronchiectasis, emphysema, or enlarged nodes. Three sputum samples sent for acid-fast smear, nucleic acid amplification, culture, and susceptibility; interferon-gamma release assay, HIV, hepatitis B, and hepatitis C tests sent. Hemoglobin 12.1 (low), platelets 442 (high), albumin 3.2 (low), ALT 18, AST 24, bilirubin 0.5, creatinine 0.78, potassium 4.0, calcium 9.0, magnesium 2.0. PHQ-9 7, item 9 scored 0; AUDIT-C 2. No medicines; no known allergies. Home airborne isolation started, lessons moved online, and the suspected case reported to the health department today",
        "questions": [
          "Do the results confirm pulmonary tuberculosis, and does anything else need to be considered?",
          "Is he eligible for the four-month rifapentine-moxifloxacin regimen, and would you choose it over the six-month regimen?",
          "What monitoring does he need, given his low weight and albumin?",
          "When can he leave isolation and teach his students again?",
          "Should cystic fibrosis or alpha-1 antitrypsin deficiency be tested for, given his lifelong chest illness?"
        ]
      },
      "consultant_note": {
        "history": "Mr. Chopin, a 28-year-old pianist who teaches in his apartment, is seen at the request of Dr. Lindqvist three days after presenting with three months of cough, two weeks of blood-streaked sputum, night sweats, evening fevers, and weight loss. He has coughed up blood once more since. He has had recurrent coughs and fevers with colds since his teens, but he has never had a diagnosis of a chronic lung disease, nasal polyps, sinus disease, greasy stools, or liver disease. He has never been treated for tuberculosis and knows of no contact with drug-resistant disease. He takes no medicines and has no history of heart rhythm problems or fainting",
        "data_reviewed": "Dr. Lindqvist's note; the chest X-ray and CT; three sputum smears (2+, 2+, 1+); the nucleic acid amplification test (Mycobacterium tuberculosis complex detected, rifampin resistance not detected); the interferon-gamma release assay (positive); HIV-1/2 antigen and antibody (negative); hepatitis B surface antigen and core antibody (negative) with surface antibody positive; hepatitis C antibody (negative); and the baseline blood count, liver and kidney tests, potassium, calcium, and magnesium",
        "exam": [
          {
            "system": "General",
            "finding": "Thin and tired; temperature 37.6 °C, pulse 98; seen in an airborne infection isolation room"
          },
          {
            "system": "Ears, nose, and throat",
            "finding": "No nasal polyps"
          },
          {
            "system": "Respiratory",
            "finding": "Coarse crackles and bronchial breathing over the right upper zone; fine crackles at the left apex"
          },
          {
            "system": "Extremities",
            "finding": "No clubbing"
          },
          {
            "system": "Musculoskeletal",
            "finding": "Tendons non-tender"
          },
          {
            "system": "Neurological",
            "finding": "Normal sensation in the fingers and feet"
          }
        ],
        "assessment": [
          {
            "problem_id": "PRB-002",
            "display": "Pulmonary tuberculosis, cavitary and smear-positive",
            "assessment": "Confirmed by a positive amplification test with three positive smears, in keeping with the cavity and the symptoms. No rifampin resistance. A positive interferon-gamma release assay supports the diagnosis but would not have excluded it if negative. Nontuberculous mycobacteria do not give a positive amplification test for the tuberculosis complex. Cultures, molecular tests for isoniazid and fluoroquinolone resistance, and phenotypic susceptibility are pending"
          },
          {
            "display": "Choice of regimen",
            "assessment": "He is eligible for the four-month regimen: age over 12, weight 48.4 kg, pulmonary disease only, HIV negative, no prolonged QT history or QT-prolonging medicines, normal potassium and magnesium, normal liver tests and creatinine, no earlier treatment, and specimens sent for susceptibility before the first dose. A cavity does not exclude it. Compared with the six-month regimen it shortens treatment by two months, which matters to him as a teacher and performer, at the cost of more tablets taken with food and the moxifloxacin precautions. He chose it after hearing both options"
          },
          {
            "display": "Monitoring",
            "assessment": "An electrocardiogram is not routinely needed, because he has no QT risk factors. His low weight and albumin justify one early liver check even without symptoms. Moxifloxacin can cause tendon injury and, with isoniazid, nerve damage, which would matter greatly to a pianist; both should be asked about at every visit and every observed dose"
          },
          {
            "display": "Isolation and return to teaching",
            "assessment": "He remains infectious until he has had at least two weeks of treatment, his symptoms are improving, and three sputum smears collected at least eight hours apart are negative. After that, with the health department's agreement, he can teach in person and needs no mask"
          },
          {
            "display": "Cystic fibrosis and alpha-1 antitrypsin deficiency",
            "assessment": "Neither is likely: the CT shows no bronchiectasis or emphysema, he has no sinus or pancreatic symptoms, and tuberculosis fully explains his illness. Because his lifelong chest illness raises the question and he wants it answered, a sweat chloride test and a serum alpha-1 antitrypsin level are reasonable and simple; a sweat chloride below 30 mmol/L makes cystic fibrosis unlikely"
          },
          {
            "problem_id": "PRB-003",
            "display": "Moderate protein-calorie malnutrition",
            "assessment": "Undernutrition raises the risk of poor outcomes and drug toxicity; pyridoxine is needed with isoniazid"
          }
        ],
        "recommendations": [
          "Start today: rifapentine 1200 mg, moxifloxacin 400 mg, isoniazid 300 mg, and pyrazinamide 1000 mg (weight band 40 to under 55 kg) once daily with food for eight weeks (56 doses), then rifapentine, moxifloxacin, and isoniazid for nine weeks (63 doses), with pyridoxine 50 mg, all by video-observed therapy seven days a week; the regimen is complete at 119 doses, with the intensive phase within 70 days and the whole regimen within five months",
          "No mineral supplements, antacids, or zinc products within four hours before or eight hours after the dose; review any new medicine for interactions with rifapentine or for QT effects with moxifloxacin",
          "Liver tests in two to three weeks and at once for hepatitis symptoms; stop the doses and call for ALT above three times the upper limit with symptoms or five times without",
          "Ask about tendon pain and numbness or tingling at every visit; stop moxifloxacin for tendon pain",
          "Three sputum smears in the third week for release from isolation; monthly sputum culture until two are negative, including the two-month culture; send any positive two-month culture for repeat susceptibility testing",
          "Phenotypic susceptibility to rifampin, isoniazid, pyrazinamide, and moxifloxacin on the first isolate; change the regimen if any resistance is found",
          "Sweat chloride test and serum alpha-1 antitrypsin level at the next visit, once he is out of isolation",
          "Dietitian support with supplement drinks taken in the afternoon or evening, away from the dose",
          "No electrocardiogram unless symptoms or a new QT-prolonging medicine arise",
          "I will review the results by message at two months and at the end of treatment; no further infectious diseases visit unless the cultures stay positive, resistance is found, or a drug must be stopped"
        ],
        "communication": "Discussed with Dr. Lindqvist, who saw him the same morning, and with the health department tuberculosis nurse who will observe his doses by video. The regimen, its precautions, and the release criteria were explained to Mr. Chopin, who chose the four-month regimen and asked for written advice for his students; the health department will contact them directly",
        "follow_up": "Results review by message at two months and at the end of treatment; sooner for liver injury, tendon pain, positive cultures at two months, or resistance"
      },
      "guideline_ids": [
        "GL-CDC-4MO-2022",
        "GL-ATS-TB-2016",
        "GL-ATS-TB-2025",
        "GL-ATS-HEPATOTOX-2006",
        "GL-CDC-CONTACT-2005",
        "GL-CFF-DX-2017",
        "GL-ATS-A1AT-2003"
      ]
    }
  },
  "care_plan": {
    "health_concerns": [
      {
        "id": "HC-001",
        "display": "He has coughed for about three months, now with streaks of blood, sweats at night, and has lost weight; he wants to know what is wrong",
        "status": "active",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0004",
            "CLM-0020"
          ],
          "synthetic_reason": "Synthetic patient-centered concern.",
          "author": "The Human Record generator",
          "created": "2026-11-02T15:00:00-05:00"
        }
      },
      {
        "id": "HC-002",
        "display": "He teaches piano at home and performs; he wants to know when he can teach again and whether his students are at risk",
        "status": "active",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0006"
          ],
          "synthetic_reason": "Synthetic patient-centered concern.",
          "author": "The Human Record generator",
          "created": "2026-11-02T15:00:00-05:00"
        }
      },
      {
        "id": "HC-003",
        "display": "He is afraid his students and neighbors will shun him if they learn he may have tuberculosis",
        "status": "active",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0010"
          ],
          "synthetic_reason": "Synthetic patient-centered concern, echoing the documented fear of his illness on Majorca.",
          "author": "The Human Record generator",
          "created": "2026-11-02T15:00:00-05:00"
        }
      }
    ],
    "goals": [
      {
        "id": "GOAL-001",
        "display": "Complete all 119 doses within five months by video-observed therapy",
        "status": "completed",
        "target_date": "2026-07-21",
        "outcome": "All 119 doses completed in 17 weeks: 56 in the intensive phase and 63 in the continuation phase, with none missed",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic treatment-completion goal.",
          "author": "The Human Record generator",
          "created": "2026-11-02T15:00:00-05:00"
        }
      },
      {
        "id": "GOAL-002",
        "display": "Sputum culture negative at two months",
        "status": "completed",
        "target_date": "2026-07-21",
        "outcome": "The two-month culture showed no growth, as did the cultures from the third week",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic culture-conversion goal.",
          "author": "The Human Record generator",
          "created": "2026-11-02T15:00:00-05:00"
        }
      },
      {
        "id": "GOAL-003",
        "display": "Return to teaching once the health department confirms he is no longer infectious",
        "status": "completed",
        "target_date": "2026-04-07",
        "outcome": "Released from isolation after three negative smears and more than two weeks of treatment; teaching again from the third week",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic occupational goal.",
          "author": "The Human Record generator",
          "created": "2026-11-02T15:00:00-05:00"
        }
      },
      {
        "id": "GOAL-004",
        "display": "Weight back to at least 55 kg by the end of treatment",
        "status": "completed",
        "target_date": "2026-07-21",
        "outcome": "55.0 kg at the end of treatment, from 48.5 kg at diagnosis",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic nutrition goal.",
          "author": "The Human Record generator",
          "created": "2026-11-02T15:00:00-05:00"
        }
      },
      {
        "id": "GOAL-005",
        "display": "PHQ-9 below 5 by the end of treatment",
        "status": "completed",
        "target_date": "2026-07-21",
        "outcome": "PHQ-9 3 at the end of treatment, from 7 at diagnosis",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic mood goal.",
          "author": "The Human Record generator",
          "created": "2026-11-02T15:00:00-05:00"
        }
      }
    ],
    "interventions": [
      {
        "id": "INT-001",
        "display": "Infectious diseases consultation to confirm the diagnosis, choose between the six-month and four-month regimens, plan monitoring and his return to teaching, and address cystic fibrosis and alpha-1 antitrypsin deficiency as explanations for his lifelong chest illness",
        "status": "completed",
        "guideline_ids": [
          "GL-ATS-TB-2016",
          "GL-CDC-4MO-2022"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0004",
            "CLM-0014",
            "CLM-0016"
          ],
          "synthetic_reason": "Synthetic specialist consultation.",
          "author": "The Human Record generator",
          "created": "2026-11-02T15:00:00-05:00"
        }
      },
      {
        "id": "INT-002",
        "display": "Diagnosis: three sputum samples at least eight hours apart, one early in the morning, for acid-fast smear, nucleic acid amplification with rifampin resistance, culture, molecular testing for isoniazid and fluoroquinolone resistance, and phenotypic susceptibility; an interferon-gamma release assay; HIV, hepatitis B, and hepatitis C tests; and baseline blood count, liver and kidney tests, potassium, calcium, and magnesium",
        "status": "completed",
        "guideline_ids": [
          "GL-ATS-TB-2016",
          "GL-CDC-4MO-2022"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0004",
            "CLM-0020"
          ],
          "synthetic_reason": "Synthetic diagnostic plan.",
          "author": "The Human Record generator",
          "created": "2026-11-02T15:00:00-05:00"
        }
      },
      {
        "id": "INT-003",
        "display": "Infection control and public health: home airborne isolation with no students or visitors and a surgical mask around others; same-day report of suspected tuberculosis to the health department; a contact investigation of his students, friends, and other close contacts led by the health department",
        "status": "completed",
        "guideline_ids": [
          "GL-CDC-CONTACT-2005",
          "GL-ATS-TB-2016"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0004",
            "CLM-0020"
          ],
          "synthetic_reason": "Synthetic public-health plan.",
          "author": "The Human Record generator",
          "created": "2026-11-02T15:00:00-05:00"
        }
      },
      {
        "id": "INT-004",
        "display": "Nutrition: two dietitian visits in the first month, three meals and three energy-dense snacks a day, two oral nutrition supplement drinks a day, and weight at every visit",
        "status": "completed",
        "guideline_ids": [
          "GL-ASPEN-MALN-2012",
          "GL-ATS-TB-2016"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0004",
            "CLM-0007"
          ],
          "synthetic_reason": "Synthetic nutrition plan.",
          "author": "The Human Record generator",
          "created": "2026-11-02T15:00:00-05:00"
        }
      },
      {
        "id": "INT-005",
        "display": "Support: plain information about how tuberculosis spreads, how quickly treatment makes him non-infectious, and that it is curable; help with what to tell his students; PHQ-9 at diagnosis, at two months, and at the end of treatment",
        "status": "completed",
        "guideline_ids": [
          "GL-USPSTF-DEP-2023",
          "GL-ATS-TB-2016"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0010"
          ],
          "synthetic_reason": "Synthetic support plan.",
          "author": "The Human Record generator",
          "created": "2026-11-02T15:00:00-05:00"
        }
      },
      {
        "id": "INT-006",
        "display": "Treatment: the four-month regimen of rifapentine 1200 mg, moxifloxacin 400 mg, isoniazid 300 mg, and pyrazinamide 1000 mg daily with food for eight weeks, then rifapentine, moxifloxacin, and isoniazid for nine weeks, with pyridoxine, by video-observed therapy seven days a week; complete when 119 doses are taken within five months",
        "status": "completed",
        "guideline_ids": [
          "GL-CDC-4MO-2022",
          "GL-ATS-TB-2025",
          "GL-ATS-TB-2016"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0004",
            "CLM-0014",
            "CLM-0016"
          ],
          "synthetic_reason": "Synthetic treatment plan chosen with him at the results visit.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:00:00-05:00"
        },
        "recorded_date": "2026-03-20"
      },
      {
        "id": "INT-007",
        "display": "Monitoring: symptoms, weight, adverse effects (liver, tendons, nerves) and observed doses at every visit; liver tests at two to three weeks and for symptoms; sputum smears in the third week for release, then monthly culture until two are negative, including the two-month culture; phenotypic susceptibility including moxifloxacin; PHQ-9 at two months and at the end",
        "status": "completed",
        "guideline_ids": [
          "GL-CDC-4MO-2022",
          "GL-ATS-HEPATOTOX-2006"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0004",
            "CLM-0014",
            "CLM-0016"
          ],
          "synthetic_reason": "Synthetic monitoring plan.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:00:00-05:00"
        },
        "recorded_date": "2026-03-20"
      },
      {
        "id": "INT-008",
        "display": "Sweat chloride test and serum alpha-1 antitrypsin level once he is out of isolation, to address cystic fibrosis and alpha-1 antitrypsin deficiency as the proposed alternatives",
        "status": "completed",
        "guideline_ids": [
          "GL-CFF-DX-2017",
          "GL-ATS-A1AT-2003"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0017",
            "CLM-0018"
          ],
          "synthetic_reason": "Synthetic tests advised by infectious diseases.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:00:00-05:00"
        },
        "recorded_date": "2026-03-20"
      }
    ],
    "guidelines": [
      {
        "guideline_id": "GL-ATS-TB-2016",
        "title": "Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis",
        "publisher": "American Thoracic Society, Centers for Disease Control and Prevention, and Infectious Diseases Society of America (Clinical Infectious Diseases)",
        "url": "https://pubmed.ncbi.nlm.nih.gov/27621353/",
        "version_or_year": "2016"
      },
      {
        "guideline_id": "GL-CDC-4MO-2022",
        "title": "Interim Guidance: 4-Month Rifapentine-Moxifloxacin Regimen for the Treatment of Drug-Susceptible Pulmonary Tuberculosis - United States, 2022",
        "publisher": "Centers for Disease Control and Prevention (MMWR)",
        "url": "https://www.cdc.gov/mmwr/volumes/71/wr/mm7108a1.htm",
        "version_or_year": "2022"
      },
      {
        "guideline_id": "GL-ATS-TB-2025",
        "title": "Updates on the Treatment of Drug-Susceptible and Drug-Resistant Tuberculosis: An Official ATS/CDC/ERS/IDSA Clinical Practice Guideline",
        "publisher": "American Thoracic Society, Centers for Disease Control and Prevention, European Respiratory Society, and Infectious Diseases Society of America (American Journal of Respiratory and Critical Care Medicine)",
        "url": "https://pubmed.ncbi.nlm.nih.gov/40693952/",
        "version_or_year": "2025"
      },
      {
        "guideline_id": "GL-ATS-HEPATOTOX-2006",
        "title": "An official ATS statement: hepatotoxicity of antituberculosis therapy",
        "publisher": "American Thoracic Society (American Journal of Respiratory and Critical Care Medicine)",
        "url": "https://pubmed.ncbi.nlm.nih.gov/17021358/",
        "version_or_year": "2006"
      },
      {
        "guideline_id": "GL-CDC-CONTACT-2005",
        "title": "Guidelines for the investigation of contacts of persons with infectious tuberculosis: recommendations from the National Tuberculosis Controllers Association and CDC",
        "publisher": "Centers for Disease Control and Prevention (MMWR Recommendations and Reports)",
        "url": "https://pubmed.ncbi.nlm.nih.gov/16357823/",
        "version_or_year": "2005"
      },
      {
        "guideline_id": "GL-CFF-DX-2017",
        "title": "Diagnosis of Cystic Fibrosis: Consensus Guidelines from the Cystic Fibrosis Foundation",
        "publisher": "Cystic Fibrosis Foundation (Journal of Pediatrics)",
        "url": "https://pubmed.ncbi.nlm.nih.gov/28129811/",
        "version_or_year": "2017"
      },
      {
        "guideline_id": "GL-ATS-A1AT-2003",
        "title": "American Thoracic Society/European Respiratory Society statement: standards for the diagnosis and management of individuals with alpha-1 antitrypsin deficiency",
        "publisher": "American Thoracic Society and European Respiratory Society (American Journal of Respiratory and Critical Care Medicine)",
        "url": "https://pubmed.ncbi.nlm.nih.gov/14522813/",
        "version_or_year": "2003"
      },
      {
        "guideline_id": "GL-ASPEN-MALN-2012",
        "title": "Consensus statement: Academy of Nutrition and Dietetics and American Society for Parenteral and Enteral Nutrition: characteristics recommended for the identification and documentation of adult malnutrition (undernutrition)",
        "publisher": "Academy of Nutrition and Dietetics and American Society for Parenteral and Enteral Nutrition (JPEN)",
        "url": "https://pubmed.ncbi.nlm.nih.gov/22535923/",
        "version_or_year": "2012"
      },
      {
        "guideline_id": "GL-USPSTF-DEP-2023",
        "title": "Depression and Suicide Risk in Adults: Screening",
        "publisher": "U.S. Preventive Services Task Force",
        "url": "https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/screening-depression-suicide-risk-adults",
        "version_or_year": "2023"
      },
      {
        "guideline_id": "GL-ARTI-2016",
        "title": "Appropriate Antibiotic Use for Acute Respiratory Tract Infection in Adults: Advice for High-Value Care From the American College of Physicians and the Centers for Disease Control and Prevention",
        "publisher": "American College of Physicians and Centers for Disease Control and Prevention (Annals of Internal Medicine)",
        "url": "https://pubmed.ncbi.nlm.nih.gov/26785402/",
        "version_or_year": "2016"
      },
      {
        "guideline_id": "GL-PREV-2026",
        "title": "Medicare Preventive Services reference: visit templates, screening cascades, and documentation elements",
        "publisher": "Aether Forge",
        "url": "https://patrickrutledge.github.io/preventative_services/",
        "version_or_year": "2026"
      },
      {
        "guideline_id": "GL-USPSTF-AB",
        "title": "USPSTF A and B Recommendations",
        "publisher": "U.S. Preventive Services Task Force",
        "url": "https://www.uspreventiveservicestaskforce.org/uspstf/recommendation-topics/uspstf-a-and-b-recommendations",
        "version_or_year": "2026"
      },
      {
        "guideline_id": "GL-CDC-ADULT-2026",
        "title": "Adult Immunization Schedule by Age",
        "publisher": "Centers for Disease Control and Prevention",
        "url": "https://www.cdc.gov/vaccines/hcp/imz-schedules/adult-age.html",
        "version_or_year": "2026"
      }
    ]
  },
  "review": {
    "schema_validation": {
      "status": "not_started",
      "notes": "Run scripts/build.ps1 -Conformance."
    },
    "clinical_review": {
      "status": "not_started",
      "notes": "Awaiting clinician review."
    },
    "provenance_review": {
      "status": "not_started",
      "notes": "Biography from the Fryderyk Chopin Institute, the Polish Music Information Centre, and the Valldemossa museum page; retrospective diagnoses from PubMed records. The birth-date conflict (March 1 or February 22, 1810) is recorded. Tuberculosis is graded D as diagnosed in his lifetime and R (probable) for the 2014 heart examination; cystic fibrosis, alpha-1 antitrypsin deficiency, and heart failure are R and disputed."
    },
    "safe_messaging_review": {
      "status": "not_started",
      "notes": "The two claims about low mood are marked sensitive and quoted in the source's lay words, not as diagnoses. PHQ-9 at most 7 and no F-code, so no safety assessment is required; item 9 is recorded at each PHQ-9. George Sand appears only in documented history claims; contacts in the investigation are synthetic and unnamed, and no result is attributed to anyone."
    }
  }
}
